<SEC-DOCUMENT>0001104659-20-096879.txt : 20200819
<SEC-HEADER>0001104659-20-096879.hdr.sgml : 20200819
<ACCEPTANCE-DATETIME>20200819160551
ACCESSION NUMBER:		0001104659-20-096879
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20200819
DATE AS OF CHANGE:		20200819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ClearSign Technologies Corp
		CENTRAL INDEX KEY:			0001434524
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-232402
		FILM NUMBER:		201117143

	BUSINESS ADDRESS:	
		STREET 1:		12870 INTERURBAN AVENUE SOUTH
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98168
		BUSINESS PHONE:		(206) 673-4848

	MAIL ADDRESS:	
		STREET 1:		12870 INTERURBAN AVENUE SOUTH
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98168

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLEARSIGN COMBUSTION CORP
		DATE OF NAME CHANGE:	20080507
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>tm2028978-1_424b2.htm
<DESCRIPTION>424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(2)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-232402</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="padding: 1pt; color: Red; border: Black 2.25pt double; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This preliminary prospectus
supplement relates to an effective registration statement under the Securities Act of 1933 but is not complete and may be changed.
This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting
an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</P>

<P STYLE="color: red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="color: Red">SUBJECT
TO COMPLETION, DATED AUGUST 19, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PRELIMINARY PROSPECTUS SUPPLEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(To the Prospectus Dated July 12, 2019)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.25in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm2028978-1_424b2img001.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are offering shares of our common stock,
par value $0.0001 per share, pursuant to this prospectus supplement and accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is listed on the NASDAQ
Capital Market under the symbol &#8220;CLIR.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On August 18, 2020, the last completed trading
day prior to the date of this prospectus supplement, the last reported sale price of our common stock on the NASDAQ Capital Market
was $2.30 per share. The aggregate market value of our outstanding voting common stock held by non-affiliates, based on the closing
price of our common stock on August 18, 2020 of $2.30 per share was $47,851,558. Except for the shares of common stock offered pursuant
to this prospectus supplement and accompanying prospectus, we have not offered any securities during the 12 calendar month period
that ends on, and includes, the date of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.25in">
<TR STYLE="vertical-align: top">
    <TD STYLE="border: Black 1pt solid; width: 52%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; width: 24%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Share</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 24%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total (2)</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public offering price</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discount and commission (1)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds to us, before expenses</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in">(1) The underwriter will be reimbursed $35,000 for
certain expenses incurred in this offering. See &#8220;Underwriting&#8221; for details.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in">(2) Assumes no exercise of the underwriter&#8217;s
over-allotment option described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>An investment in our common stock involves
a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page S-7 of this prospectus supplement, and the risk factors
incorporated by reference into this prospectus supplement and the accompanying prospectus, for more information on these risks.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities, or passed upon the adequacy or accuracy of
this prospectus supplement. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have granted the underwriter an option
for a period of 20 days to purchase up to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of our common stock at the public offering price, less the underwriting
discount, to cover over-allotments, if any. If the underwriter exercises the option in full, the total underwriting discount will
be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , and the total proceeds to us, before expenses, will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We anticipate delivery of the shares will
be made on or about August &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2020, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>National Securities Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus supplement is
August &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
    OF CONTENTS</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus
    Supplement</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_01"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
    THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_01"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_02"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSURE
    REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_02"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-2</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_03"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS
    SUPPLEMENT SUMMARY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_03"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-3</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_04"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK
    FACTORS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_04"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-7</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_05"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE
    OF PROCEEDS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_05"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_06"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND
    POLICY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_06"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_07"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DILUTION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_07"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_08"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERWRITING</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_08"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-11</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_09"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL
    MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_09"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-15</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_10"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_10"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-15</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_11"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE
    YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_11"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-15</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_12"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION
    INCORPORATED BY REFERENCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#ps_12"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-15</FONT></A></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: left; vertical-align: bottom"><FONT STYLE="font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Prospectus</B></FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">MARKET, INDUSTRY AND OTHER DATA</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">2</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">OUR BUSINESS</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">DILUTION</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">DESCRIPTION OF SECURITIES THAT MAY BE OFFERED</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">8</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">Description
of Debt Securities</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">8</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">Description
of Common Stock</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">15</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">Description
of Preferred Stock</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">18</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">Description
of Warrants</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">18</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">Description
of Units</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">19</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">Description
of Subscription Rights</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">20</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">21</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_016"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_016"><FONT STYLE="font-size: 10pt">23</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_017"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_017"><FONT STYLE="font-size: 10pt">23</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_018"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_018"><FONT STYLE="font-size: 10pt">23</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_019"><FONT STYLE="font-size: 10pt">INFORMATION INCORPORATED BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_019"><FONT STYLE="font-size: 10pt">24</FONT></A></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_01"></A>ABOUT THIS PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This document is in two parts. The first
part is the prospectus supplement, including the documents incorporated by reference, which describes the specific terms of this
offering. The second part, the accompanying prospectus, including the documents incorporated by reference, provides more general
information. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. We urge you
to carefully read this prospectus supplement and the accompanying prospectus, and the documents incorporated by reference herein
and therein, before buying any of the securities being offered under this prospectus supplement. This prospectus supplement may
add, update or change information contained in the accompanying prospectus. To the extent that any statement that we make in this
prospectus supplement is inconsistent with statements made in the accompanying prospectus or any documents incorporated by reference
therein filed prior to the date of this prospectus supplement, the statements made in this prospectus supplement will be deemed
to modify or supersede those made in the accompanying prospectus and such documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should rely only on the information
contained or incorporated herein by reference in this prospectus supplement and contained or incorporated therein by reference
in the accompanying prospectus. We have not authorized anyone to provide you with different or additional information. If anyone
provides you with different, additional or inconsistent information, you should not rely on it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are offering to sell the securities only
in jurisdictions where such offers and sales are permitted. The distribution of this prospectus supplement and the accompanying
prospectus and the offering of the securities in certain jurisdictions or to certain persons within such jurisdictions may be restricted
by law. Persons outside the United States who come into possession of this prospectus supplement and the accompanying prospectus
must inform themselves about and observe any restrictions relating to the offering of the securities and the distribution of this
prospectus supplement and the accompanying prospectus outside the United States. This prospectus supplement and the accompanying
prospectus do not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any
securities offered by this prospectus supplement and the accompanying prospectus by any person in any jurisdiction in which it
is unlawful for such person to make such an offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should assume that the information in
this prospectus supplement and the accompanying prospectus is accurate only as of the date on the front of the applicable document
and that any information we have incorporated by reference is accurate only as of the date of the document incorporated by reference,
regardless of the time of delivery of this prospectus supplement or the accompanying prospectus, or any sale of a security. Our
business, financial condition, results of operations and prospects may have changed since those dates. You should read this prospectus
supplement, the accompanying prospectus and the documents incorporated by reference in this prospectus supplement and the accompanying
prospectus when making your investment decision. You should also read and consider the information in the documents we have referred
you to in the sections of this prospectus supplement and the accompanying prospectus titled &#8220;Where You Can Find More Information&#8221;
and &#8220;Information Incorporated by Reference.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The representations, warranties and covenants
made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein or in the accompanying
prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating
risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover,
such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties
and covenants should not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement, the accompanying
prospectus, and the information incorporated herein and therein by reference includes trademarks, service marks and trade names
owned by us or other companies. All trademarks, service marks and trade names included or incorporated by reference into this prospectus
supplement or the accompanying prospectus are the property of their respective owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In this prospectus supplement, unless otherwise
stated or the context otherwise requires, the terms &#8220;ClearSign,&#8221; &#8220;ClearSign Technologies,&#8221; &#8220;we,&#8221;
&#8220;us,&#8221; &#8220;our,&#8221; and the &#8220;Company&#8221; refer collectively to ClearSign Technologies Corporation and
its subsidiary, ClearSign Asia Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_02"></A>DISCLOSURE REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement, the accompanying
prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus contain
forward-looking statements within the meaning of applicable securities laws. Forward-looking statements give our current expectations
or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or
current facts. You can find many (but not all) of these statements by looking for words such as &#8220;approximates,&#8221; &#8220;believes,&#8221;
&#8220;hopes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221;
&#8220;plans,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;will&#8221; or other
similar expressions in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein
and therein. These statements may be found under the sections entitled &#8220;Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations,&#8221; &#8220;Our Business&#8221; and &#8220;Risk Factors&#8221; included or incorporated
by reference into this prospectus supplement or the accompanying prospectus, as well as in this prospectus supplement generally.
In particular, these include statements relating to future actions; prospective products, applications, customers and technologies;
future performance or results of anticipated products; anticipated expenses; and future financial results. These forward-looking
statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical
experience and our present expectations or projections. Factors that could cause actual results to differ from those discussed
in the forward-looking statements include, but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our history of losses;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to successfully develop and implement our technology and achieve profitability;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our limited operating history;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">emerging competition and rapidly advancing technology in our industry that may outpace our technology;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in government regulations that could substantially reduce, or even eliminate, the need for our technology;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to protect our intellectual property;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of a cybersecurity incident or other technology disruption; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">customer demand for the products and services we develop;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of competitive or alternative products, technologies and pricing;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to manufacture any products we design;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to hire and retain personnel with the experience and talent to develop our products and business;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in; width: 48px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic conditions and events and the impact they may have on us and our potential customers;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our doing business in China and related risks with respect to intellectual property protection, currency exchange, contract enforcement and rules on foreign investment;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the financial and operational impacts of the coronavirus pandemic on our business and results of operations, including impacts on our day-to-day operations, collaborative arrangements, revenue and marketing efforts and suppliers;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to obtain adequate financing in the future;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to continue as a going concern;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our success at managing the risks involved in the foregoing items; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other factors discussed in this prospectus supplement or the documents incorporated by reference herein.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The forward-looking statements are based
upon management&#8217;s beliefs and assumptions and are made as of the date of this prospectus supplement. We undertake no obligation
to publicly update or revise any forward-looking statements included in or incorporated by reference into this prospectus supplement
or to update the reasons why actual results could differ from those contained in such statements, whether as a result of new information,
future events or otherwise, except to the extent required by federal securities laws. Actual future results may vary materially
as a result of various factors, including, without limitation, the risks outlined under the section of this prospectus supplement
and the accompanying prospectus entitled &#8220;Risk Factors&#8221; and matters described in this prospectus generally. In light
of these risks and uncertainties, we cannot assure you that the forward-looking statements contained in this prospectus will in
fact occur. You should not place undue reliance on these forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Third-Party Data</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We obtained statistical data, market data
and other industry data and forecasts used throughout this prospectus from publicly available information. While we believe that
the statistical data, market data and other industry data and forecasts are reliable and we are responsible for all of the disclosure
in this prospectus supplement, we have not independently verified the data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 0.5; border: Black 1pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_03"></A>PROSPECTUS SUPPLEMENT SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>This is only a summary and may not contain
all the information that is important to you. You should carefully read both this prospectus supplement and the accompanying prospectus
and any other offering materials, together with the additional information described under the heading &#8220;Where You Can Find
More Information.&#8221;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">ClearSign Technologies designs and develops
industry-leading technologies that have been shown to significantly improve key performance characteristics of combustion systems,
including emission and operational performance, energy efficiency, safety, and overall cost-effectiveness. We believe that our
patented technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream
oil production and down-stream refining), institutional, commercial and industrial boiler, chemical, and petrochemical industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To date, our operations have been funded
primarily through sales of our equity securities. We have earned limited revenue since inception. We were incorporated on January
23, 2008 in the state of Washington under the name ClearSign Combustion Corporation and, on November 12, 2019, we changed our name
to ClearSign Technologies Corporation. Our principal executive offices are located at 12870 Interurban Avenue South, Seattle, Washington
98168 and we have an office in Tulsa, Oklahoma. Our telephone number is (206) 673-4848. Our website can be accessed at www.clearsign.com.
The information contained on or that may be obtained from our website is not a part of this prospectus supplement. Substantially
all of our operations are located in the United States, though we are developing sales relationships outside of the United States,
particularly in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the results of customer feedback
and our testing, we believe our technologies compare favorably with current industry-standard air pollution control technologies,
such as selective catalytic reduction devices, low- and ultra-low NOx burners (which address nitrogen oxides or NOx), excess air
systems and other similar technologies. Such systems are used in our current target market segments of petroleum refining and petrochemical
process heaters, large-scale once through steam generators (&#8220;OTSGs&#8221;), enclosed ground flares, and packaged boilers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Industry</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The combustion and emissions control markets
are significant, both in the wide array of industries in which the systems are used and in the amount of money spent in installing
and upgrading systems. These are used to provide heat for all manner of industrial processes, including boilers, furnaces, kilns
and turbines. In order to maximize energy efficiency while keeping pace with regulatory guidelines for air pollution emissions,
operators of these systems are continually installing, maintaining and upgrading a variety of costly process control, air pollution
control and monitoring systems. Although we believe that there are many potential markets for our technologies, to date we have
limited the introduction of our technologies to market segments that include petroleum refining process heaters, industrial and
commercial boilers, enclosed ground flares, and OTSGs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Proprietary Technology</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The name &#8220;ClearSign Core&#8221;
was adopted to describe the inclusion of ClearSign&#8217;s burner technology in the products of original equipment burner
manufacturers, providing those manufacturers with a new product range with the unique capability of the ClearSign technology.
This will allow ClearSign to leverage our technology and allow our prospective original equipment manufacturer
(&#8220;OEM&#8221;) partners to combine their global manufacturing, order fulfillment and service capabilities with what we
believe is a distinctively differentiated product performance. Our ClearSign Core burner technology consists of an industrial
burner body and a downstream porous ceramic structure. When the unreacted mix of gaseous fuel and air is directed at the
ceramic structure, the mixture ignites and stabilizes within the structure itself. Because the fuel and air have more time to
mix, the homogeneous mixture mitigates NOx-forming hot spots and chemistry that are typically produced. The mixing and
combustion in the ceramic structure results in a dramatically shorter flame, and modification of the structure enables a high
level of control over the shape of the flame allowing it to be optimized for a wide range of different applications. NOx, a
regulated greenhouse gas pollutant comprised largely of nitrogen oxide and nitrogen dioxide, can be greatly reduced to levels
of 5 ppm or below, depending on the specific application, without any external fans or associated power, thereby minimizing
harmful emissions while improving system efficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 0.5; border: Black 1pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>ClearSign Core Plug &amp; Play&#8482;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our ClearSign Core Plug &amp; Play product
provides a simplified, pre-engineered and standardized direct burner replacement for traditional refinery process heaters. We believe
that this product will minimize the customized engineering associated with retrofits and lend itself to mass production. The product
is designed to allow quick and easy installation into a multi-burner heater or furnace. We believe that the simplicity of the actions
required to retrofit refinery process heaters with the ClearSign Core Plug &amp; Play will lead to increased demand for, and ultimately
sales of, our ClearSign Core burners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>ClearSign Core Boiler Burner Technology</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our ClearSign Core boiler burner technology
is, in essence, the same as the process burner technology. The details of the components are different due to the different orientation
of the boiler application, the different internal chamber dimensions and the fact that a boiler operates with a relatively high
combustion air pressure, and in the case of a small fire tube boiler, a lower fuel gas pressure. The concept of incorporating the
ClearSign Core technology into a typical OEM burner remains the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>ClearSign Core Flaring Burners</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our ClearSign Core flare technology incorporates
the same principles as our burner technology, namely directing the fuel gas, in this case typically waste gas, into an air stream
with that mixture forming a flame stabilized on a downstream ceramic structure. This technology has been configured into standard
modular designs that can be incorporated into a flame manufacturer&#8217;s flare body to provide a flare product with the extremely
low emissions production enabled by our ClearSign technology. The pods are designed with standard firing capacities, and these
are combined in varying quantities to enable flares to be produced with different firing rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have achieved emission results in multiple
applications that exceeded applicable local Best Available Control Technology (&#8220;BACT&#8221;) levels, including in multiple
installations in California related to three of our five target industries. We intend to continue to demonstrate ClearSign Core
capabilities through (i) working with local air quality officials to demonstrate the effectiveness of the technology, (ii) operating
in-place units, (iii) engineering and testing with new customers and applications, (iv) pursuing additional research and development
of new applications including applications in other vertical markets, and (v) assisting our customers in making emission results
available for designation as BACT by local regulatory bodies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 15, 2020, we announced that we had
received a purchase order from ExxonMobil to fabricate and install the Company&#8217;s ClearSign Core process burners at its Baytown,
Texas refinery. As part of the contract, ClearSign will fabricate and install burners equipped with its ClearSign Core technology
in a multiburner process heater to validate the technology&#8217;s effectiveness and utility for ExxonMobil. On August 12, 2020,
we announced a formal business development and equipment supply alliance with Zeeco Inc, a world leader in the combustion equipment
business. This relationship is expected to enable an expansion of our product range into new verticals and to provide a well-established
channel to market for ClearSign Core enabled burners globally. The agreement is contingent on the successful completion of a product
performance demonstration to be conducted at Zeeco&#8217;s Oklahoma test facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>ClearSign Eye&#8482; Flame Sensor</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The ClearSign Eye flame sensor is an electrical
flame sensor for industrial applications. Unlike the traditional and widely used technology, the ClearSign sensing electrodes do
not have to make contact with the flame. The value of our sensing technology is that it provides a very reliable alternative or
replacement technology for critical safety equipment and existing refinery burners. The current technology is typically very unreliable
and requires frequent maintenance on industrial burners. ClearSign Eye sensing technology has a universal application and is well
suited to low emission and standard burner technologies alike and so has a potential global market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 0.5; border: Black 1pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Target Markets</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We compete in the combustion and emissions
control markets. These are highly competitive industries that are currently dominated by companies that have substantially greater
financial resources than we do and established products. However, we believe, based on the testing and the field installations
completed to date, that our technologies offer a unique and powerful ability to improve emissions and operational performance,
energy efficiency, and overall cost-effectiveness, all of which are critical to our target markets. We are targeting the following
segments of the combustion market:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">process heaters for petroleum refining,</FONT></TD></TR>                                                                                                                                                                                                                                    <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">heating systems in packaged boilers,</FONT></TD></TR>                                                                                                                                                                                                                                 <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">enclosed ground flares, and</FONT></TD></TR>                                                                                                                                                                                                                        <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">larger-scale steam generation systems and power boilers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In each segment, we are marketing solutions
with our ClearSign technology that we believe could simultaneously improve both pollution control and operational efficiency characteristics
through (i) cost-effective retrofitting of our ClearSign Core technology onto existing standard system designs, and (ii) new system
designs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our target markets are greatly affected
by air emission regulations and economic conditions, including the price and profitability related to crude oil and its processing.
We believe that operators in all of our target markets are under intense pressure to meet current and proposed federal, state and
local emissions standards. The standards applicable to our target markets have been developed over the past 50 years with broad
political input. Due to the localized effects of poor air quality, we anticipate these standards to continue regardless of geopolitics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Emissions standards largely emanate from
the Clean Air Act, which is administered by the Environmental Protection Agency (&#8220;EPA&#8221;) and regulates six common criteria
air pollutants, including ground-level ozone. These regulations are enforced by state and local air quality districts as part of
their compliance plans. As regulations continue to restrict industrial emissions, we anticipate markets will continually adopt
new technology allowing them to remain compliant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, we believe that current emissions
standards in Europe, China and Canada will continue to trend towards stricter air emission standards as these jurisdictions seek
to achieve cleaner air. Existing and new emissions standards in such jurisdictions may create additional market opportunities for
us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Additional Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For a description of our business, financial
condition, results of operations and other important information regarding us, we refer you to our filings with the Securities
and Exchange Commission (&#8220;SEC&#8221;) incorporated by reference into this prospectus supplement. For instructions on how
to find copies of these documents, see &#8220;Where You Can Find More Information.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Split-Segment; Name: 001 -->
<DIV STYLE="padding: 0.5; border: Black 1pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>The Offering</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common stock offered by us pursuant to</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">this prospectus supplement</P></TD>
    <TD STYLE="width: 62%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">shares of common stock.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock outstanding before this offering</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">26,731,261 shares of common stock.</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock outstanding immediately</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">after this offering</FONT></P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(1)(2)</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price per share</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-allotment option</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have granted the underwriter an option to purchase from us, for a period of 20 days after the date of this prospectus supplement, up to an additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock to cover over-allotments, if any.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently intend to use the net proceeds from this offering for working capital, research and development, marketing and sales, and general corporate purposes.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NASDAQ Capital Market symbol</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLIR</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &ldquo;Risk Factors&rdquo; beginning on page S-7 of this prospectus
supplement, as well as the other information included in or incorporated by reference in this prospectus supplement and the accompanying
prospectus, for a discussion of risks you should carefully consider before investing in our securities.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation by Officers and Directors</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of our directors and officers have expressed an interest in participating in this offering.&nbsp;&nbsp;For further information relating to their participation, please see the section of this prospectus supplement titled &#8220;Underwriting &#8211; Purchases by Affiliates&#8221; at page S-12.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) The number of shares of our common stock to be outstanding
immediately after this offering is based on 26,731,261 shares of common stock outstanding as of June 30, 2020 and excludes, as
of that date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">2,675,744 shares of our common stock issuable upon exercise of stock
options under our 2011 Equity Incentive Plan at a weighted average exercise price of&#8201; $2.14 per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">341,382 shares of our common stock issuable upon exercise of stock
options granted outside of our 2011 Equity Incentive Plan at a weighted average exercise price of $1.80 per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">80,000 shares of our common stock reserved for issuance under outstanding
warrant agreements, at an exercise price of&#8201; $1.80 per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">738,091 shares of our common stock reserved for future issuance under
our 2011 Equity Incentive Plan; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">185,192 shares of our common stock reserved for future issuance under
our 2013 Consultant Stock Plan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) In connection with a private placement of our common
stock in July 2018, we granted to CLIRSPV, LLC a right to purchase certain new equity securities that we sell for the purpose
of raising capital, as described further under the section of this prospectus supplement titled
&ldquo;Underwriting&#8210;Purchases by Affiliates.&rdquo; The number of shares of our common stock to be outstanding
immediately after this offering excludes the up to approximately &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock that may be purchased by
CLIRSPV, LLC pursuant to this purchase right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise specifically stated, information
throughout this prospectus supplement assumes that none of our outstanding options or warrants to purchase shares of our common
stock are exercised and none of the over-allotment option granted to the underwriter is exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_04"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investing in our securities involves
a high degree of risk. Before making an investment decision, you should carefully consider the risks described below, together
with all of the other information included in this prospectus supplement, the accompanying prospectus, and the information incorporated
by reference herein and therein.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>For a discussion of additional risks
associated with our business, our intellectual property, government regulation, our industry and an investment in our securities,
see the section titled &#8220;Risk Factors&#8221; in our most recent <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920039929/tm205247d1_10k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K, as filed with the SEC on March 30, 2020</A>, and any other subsequently filed document that is also incorporated or deemed to be incorporated by reference in this
prospectus supplement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>If any of the risks described below,
or those incorporated by reference into this prospectus supplement actually occur, our business, financial condition or results
of operations could suffer. In that case, the trading price of our common stock may decline and you may lose all or part of your
investment. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not
presently known to us or that we currently deem immaterial may also affect our business, financial condition and results of operations.
Certain statements below are forward-looking statements. See the information included under the heading &#8220;Disclosure Regarding
Forward-Looking Statements.&#8221;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks Related to this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>In making your investment decision, you should rely only
on statements made in this prospectus in determining whether to purchase our securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should carefully evaluate all of the
information in this prospectus supplement. We have in the past received, and may continue in the future to receive, media coverage,
including coverage that is not directly attributable to statements made by our officers and employees, that incorrectly reports
on statements made by our officers or employees or that is misleading as a result of omitting to state information provided by
us or our officers or employees. You should rely only on the information contained in this prospectus supplement and the accompanying
prospectus in determining whether to purchase our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Management will have broad discretion as to the use of
proceeds from this offering and we may use the net proceeds in ways with which you may disagree.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We currently intend to use the net proceeds
of this offering for working capital, research and development, marketing and sales, and general corporate purposes. We have not
allocated specific amounts of the net proceeds from this offering for any of the foregoing purposes. Our management will have broad
discretion and flexibility in the application of the net proceeds from this offering and could spend the proceeds in ways that
do not improve our results of operations or enhance the value of our common stock or other securities. Accordingly, you will be
relying on the judgment of our management on the use of the net proceeds, and you will not have the opportunity, as part of your
investment decision, to assess whether the proceeds are being used appropriately. Our failure to apply these funds effectively
could have a material adverse effect on our business, delay the development of our products and cause the price of our common stock
or other securities to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>There may be future sales or other dilution of our equity
securities, which may adversely affect the market price of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are generally not restricted from
issuing additional shares of common stock, including securities that are convertible into or exchangeable for, or that
represent the right to receive, common stock. After this offering, the market price of our common stock could decline as a
result of sales of common stock or securities that are convertible into or exchangeable for, or that represent the right to
receive, common stock. We may, in the future, seek additional capital through a combination of public and private offerings
of common stock, or other securities convertible into or exchangeable for, or that represent a right to receive, common
stock. We may also participate in debt financings. To the extent that we raise additional capital through the sale of common
stock, or securities that are convertible into or exchangeable for, or that represent a right to receive, common stock, your
ownership interest will be diluted, and the market price of our common stock could be adversely affected. The incurrence of
indebtedness, if obtained, would result in increased fixed payment obligations and could involve restrictive covenants, such
as limitations on our ability to incur additional debt and other operating restrictions that could adversely impact our
ability to conduct our business. Moreover, we will issue additional shares of our common stock upon the exercise of currently
outstanding options and warrants. Such issuances may involve a significant number of our common shares at prices less than
the offering price in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Investors in this offering will experience immediate and
substantial dilution in the net tangible book value per share of the common stock they purchase.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The price at which our common stock is being
offered is substantially higher than the net tangible book value per share of our common stock outstanding prior to this offering.
Therefore, if you purchase our common stock in this offering, you will incur an immediate substantial dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in net tangible
book value per share from the price you paid, based on our financial statements as of June 30, 2020. If outstanding options or
warrants to purchase our common stock are exercised, you will experience additional dilution. For a further description of the
dilution that you will experience immediately after this offering, see &ldquo;Dilution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Furthermore, following this offering CLIRSPV
LLC, our largest shareholder, has the right to purchase common stock from us on terms and conditions no different from those offered
to the investors in this offering, so long as any such purchase does not cause CLIRSPV LLC to own 20% or more of our then outstanding
shares of common stock or hold shares with 20% or more of the voting power.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Because we do not anticipate paying any cash dividends
on our capital stock in the foreseeable future, capital appreciation, if any, will be your sole source of gain.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We plan to reinvest all of our earnings,
to the extent we have earnings, in order to continue to develop our products, to market our products, to cover operating costs
and to otherwise become and remain competitive. We do not plan to pay any cash dividends with respect to our securities in the
foreseeable future. Any future determination to pay cash dividends will be at the discretion of our board of directors and will
depend on applicable law and then-existing conditions, including our financial condition, operating results, contractual restrictions,
capital requirements, business prospects and other factors our board of directors may deem relevant. See &#8220;Dividend Policy.&#8221;
As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>There is a substantial doubt about our ability to continue
as a going concern.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our financial statements have been presented
on the basis that the Company is a going concern, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business. We have incurred net losses of $8,482,000 for the year ended December 31, 2019, and $3,354,000
for the six months ended June 30, 2020. Our technologies are currently in field development and have generated nominal revenues
from operations to date to meet our operating expenses. In order to generate meaningful revenues, the technologies must be fully
developed, gain market recognition and acceptance, and develop a critical level of successful sales and product installations.
We are currently dependent upon our ability to obtain financing from sales of our securities. These factors raise a substantial
doubt about our ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We cannot assure that our technologies will
be accepted, that we will ever earn revenues sufficient to support our operations, or that we will ever be profitable. Furthermore,
we have no committed source of financing and we cannot assure that we will be able to raise money as and when we need it to continue
our operations. If we cannot raise funds as and when we need them, we may be required to scale back our development plans or to
otherwise severely curtail, or even to cease, our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_05"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We estimate that the net proceeds from the
sale of our common stock in this offering will be approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if the underwriter exercises in full the
option to purchase additional shares of common stock, in each case, after deducting underwriting discounts and commissions and
our estimated expenses related to the offering. We currently intend to use the net proceeds from the sale of our common stock for
working capital, research and development, marketing and sales, and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The amounts and timing of our actual expenditures
will depend on numerous factors, including the factors described under &#8220;Risk Factors&#8221; in this prospectus supplement,
the accompanying prospectus and in the documents incorporated by reference herein, as well as the amount of cash used in our operations.
We may find it necessary or advisable to use the net proceeds for other purposes, and our management will have significant flexibility
in applying the net proceeds of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pending their use, we intend to invest the
net proceeds of this offering in direct and guaranteed obligations of the United States, interest-bearing, investment-grade instruments
or certificates of deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_06"></A>DIVIDEND POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have never declared or paid any cash
dividends on our shares of common stock and do not anticipate paying any cash dividends on our shares of common stock in the foreseeable
future. Payment of cash dividends, if any, in the future will be at the discretion of our board of directors and will depend on
applicable law and then-existing conditions, including our financial condition, operating results, contractual restrictions, capital
requirements, business prospects and other factors our board of directors may deem relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_07"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our net tangible book value as of June 30,
2020 was approximately $5.0 million, or $0.19 per share of our common stock. Our net tangible book value per share represents our
total tangible assets less total liabilities divided by the number of shares of our common stock outstanding on June 30, 2020.
After giving effect to the issuance and sale by us of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock in this offering at an offering price of&#8201; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share, and after deducting the underwriting discount and commission and estimated offering expenses payable by us, our pro
forma net tangible book value as of June 30, 2020 would have been approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of our common stock.
This represents an immediate increase in net tangible book value of&#8201; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to our existing shareholders and an immediate
dilution in net tangible book value of&#8201; $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to new investors purchasing shares of our common stock in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We determine dilution by subtracting the
pro forma net tangible book value per share after this offering from the offering price per share of our common stock. The following
table illustrates the dilution in net tangible book value per share to new investors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font: 10pt Times New Roman, Times, Serif">Public offering price per share</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Net tangible book value per share as of June 30, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.19</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Increase per share attributable to new investors in this offering</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pro forma net tangible book value per share after this offering</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Dilution in net tangible book value per share to new investors</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The table above does not take into account
further dilution to new investors that could occur upon the exercise of outstanding options and warrants having a per share exercise
price less than the public offering price per share in this offering. Additionally, the table above does not take into account
up to approximately shares of common stock that may be purchased by CLIRSPV LLC pursuant to the purchase right described under
the section of this prospectus supplement titled &ldquo;Underwriting&#8210;Purchases by Affiliates.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The number of shares of our outstanding
common stock reflected in the discussion and table above is based on 26,731,261 shares of common stock outstanding as of June 30,
2020, and excludes as of that date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">2,675,744 shares of our common stock issuable upon exercise of stock
options under our 2011 Equity Incentive Plan at a weighted average exercise price of&#8201; $2.14 per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">341,382 shares of our common stock issuable upon exercise of stock
options granted outside of our 2011 Equity Incentive Plan at a weighted average exercise price of $1.80 per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">80,000 shares of our common stock reserved for issuance under outstanding
warrant agreements, at an exercise price of&#8201; $1.80 per share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">738,091 shares of our common stock reserved for future issuance under
our 2011 Equity Incentive Plan; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">185,192 shares of our common stock reserved for future issuance under
our 2013 Consultant Stock Plan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent that the outstanding options
or warrants are exercised or CLIRSPV LLC exercises its purchase right, you will experience further dilution. To the extent that
the above issued options and warrants are exercised and the purchase right is exercised in full, the pro forma net tangible book
value per share of our common stock after giving effect to this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share, and the dilution in net tangible book value per share to purchasers in this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share. In addition, we may choose to raise additional capital due to market conditions or strategic considerations. To the
extent that additional capital is raised through the sale of securities, the issuance of those securities could result in further
dilution to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_08"></A>UNDERWRITING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have agreed to enter into an underwriting
agreement with the underwriter named below prior to the closing of this offering. Subject to the terms and conditions of the underwriting
agreement, we will agree to sell to the underwriter, and the underwriter will agree to purchase, at the public offering price less
the underwriting discounts and commissions set forth on the cover page of this prospectus supplement, the number of shares of our
common stock set forth opposite its name below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 82%">Underwriter</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shares</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">National Securities Corporation</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; color: rgb(253,228,208); font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Total</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The underwriter will be committed to purchase
all the shares of common stock offered by us, other than those covered by the option to purchase additional shares described below,
if it purchases any shares. The underwriting agreement will provide that the underwriter&#8217;s obligation to purchase shares
of our common stock is subject to conditions contained in the underwriting agreement, including the approval of certain legal matters
by its counsel and the receipt of officers&#8217; certificates and legal opinions. A copy of the underwriting agreement will be
filed as an exhibit to a Current Report on Form 8-K, and will be incorporated by reference into the registration statement of which
this prospectus is a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have been advised by the underwriter
that the underwriter proposes initially to offer the shares of our common stock directly to the public at the public offering price
set forth on the cover page of this prospectus supplement and to brokers and dealers at a price less a concession not in excess
of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. After the public offering of the shares, the offering price and other selling terms may be changed by the underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our securities included in this
offering may be offered or sold, directly or indirectly, nor may this prospectus supplement and any other offering material or
advertisements in connection with the offer and sales of any of our common stock be distributed or published in any jurisdiction,
except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons
who receive this prospectus supplement are advised to inform themselves about and to observe any restrictions relating to this
offering of our common stock and the distribution of this prospectus supplement. This prospectus supplement is neither an offer
to sell nor a solicitation of any offer to buy any of our common stock included in this offering in any jurisdiction where that
would not be permitted or legal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Underwriting Discount and Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes the underwriting
discount and commission to be paid to the underwriter by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border: Black 1pt solid; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; width: 18%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Share</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 20%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Without over-allotment</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 21%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total With over-allotment</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public offering price</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts and commissions</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accountable expense allowance</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net proceeds before other expenses</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We estimate the total expenses payable by
us for this offering to be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
, which amount includes (i) the underwriting discount of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
($&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if the underwriter&rsquo;s
over-allotment option is exercised in full), (ii) a non-accountable expense allowance of $35,000, and (iii) other estimated expenses
of the Company of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
, which includes legal, accounting, printing costs and various fees associated with the registration and listing of the shares
being sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Over-allotment Option</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have granted to the underwriter an
option, exercisable not later than 20 days after the date of this prospectus supplement, to purchase up to an additional
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock at the public offering price, less the underwriting
discount, set forth on the cover page of this prospectus supplement. The underwriter may exercise the option solely to cover
over-allotments, if any, made in connection with this offering. If any additional shares of our common stock are purchased
pursuant to the over-allotment option, the underwriter will offer these additional shares of our common stock on the same
terms as those on which the other shares of common stock are being offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Purchases by Affiliates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Purchases by Directors and Officers</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">The underwriter has received indications
of interest for the purchase of an aggregate of approximately shares of common stock sold in this offering by certain directors
and officers of the Company, including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, at the public offering price set forth on the cover page of this prospectus supplement.
Because indications of interest are not binding agreements or commitments to purchase, the underwriter may sell more, less or no
shares in this offering to any of these persons, or any of these persons may determine to purchase more, less or no shares in this
offering. The underwriter will receive the same underwriting discounts and commissions on any shares purchased by these persons
as it will on any other shares sold to the public in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>CLIRSPV LLC Purchase Right</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with a private placement of
our common stock, pursuant to a Stock Purchase Agreement dated July 12, 2018, we granted to CLIRSPV LLC a right to purchase certain
new equity securities that we sell for the purpose of raising capital on terms and conditions no different from those offered to
other purchasers. In no event, however, may this purchase right be exercised to the extent it would cause CLIRSPV LLC to own 20%
or more of the Company&rsquo;s then outstanding shares of common stock or hold shares with 20% or more of the voting power of the
Company. In connection with this purchase right, we have granted to CLIRSPV LLC the right to purchase up to approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
unregistered shares of our common stock (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares if the underwriter&rsquo;s over-allotment
option is exercised in full) at the public offering price per share in the offering, provided that such right must be exercised
by September 30, 2020 or 37 days following the closing of the underwriter&rsquo;s over-allotment option, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Robert T. Hoffman Sr., a member of our board
of directors, is the managing member of GPCLIRSPV LLC, which is the managing member of CLIRSPV LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Lock-Up Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our officers, directors and our largest
shareholder have agreed that, for a period of 90 days from the date of this prospectus supplement, they will not, subject to certain
exceptions, offer, announce the intention to sell, sell, assign, transfer, pledge, contract to sell, sell any option or contract
to purchase, make any short sale or otherwise transfer or dispose of any shares of our common stock or securities convertible into
or exercisable for our common stock, or enter into any swap, hedge or similar agreement or arrangement that transfers the economic
consequences of ownership of such securities, without the prior written consent of the underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has agreed that, for a period
of 90 days from the date of this prospectus supplement, it will not, without the prior written consent of the underwriter (a) offer,
announce the intention to sell, sell, assign, transfer, pledge, contract to sell, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, any shares
of our common stock or any securities convertible into or exercisable or exchangeable for shares of our common stock or (b) enter
into any swap, hedge or similar agreement or arrangement that transfers in whole or in part the economic consequences of ownership
of common stock, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of shares of our
common stock or such other securities, in cash or otherwise. These restrictions do not apply to (i) the issuance by us of common
stock in this offering, (ii) the issuance by us of common stock or options pursuant to any of our equity incentive plans, (iii)
the issuance of common stock upon exercise of outstanding options or warrants, (iv) the issuance of securities in connection with
acquisitions or similar transactions, (v) our issuance of a warrant to a lender in connection with a debt financing, (vi) common
stock purchased in the public market after the date of the underwriting agreement, or (vii) shares issued to CLIRSPV LLC pursuant
to the purchase right described above. We have also agreed not to accelerate the vesting of any option or warrant or the lapse
of any repurchase right and not to file any registration statement, preliminary prospectus or prospectus under the Securities Act
registering, or offering for sale, our common stock or securities convertible into or exercisable for our common stock, during
such period, except for a registration statement on Form S-8 relating to employee benefit plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Indemnification</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have agreed to indemnify the underwriter,
its officers, directors, managers, members, employees, representatives and agents, and each person, if any, who controls the underwriter
within the meaning of Section 15 of the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;), against certain liabilities,
including civil liabilities arising under the Securities Act, resulting from this offering and to contribute to payments that the
underwriter may be required to make for these liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Price Stabilization, Short Positions and Penalty Bids</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with this offering, the underwriter
may engage in transactions that stabilize, maintain or otherwise affect the price of our shares of common stock during and after
the offering. Specifically, the underwriter may over-allot in connection with this offering by selling more shares of common stock
than are set forth on the cover page of this prospectus supplement. This creates a short position in our offered shares for its
own account. The short position may be either a covered short position or a naked short position. In a covered short position,
the number of shares over-allotted by the underwriter is not greater than the number of shares that they may purchase in the over-allotment
option. In a naked short position, the number of shares involved is greater than the number of shares in the over-allotment option.
To close out a short position, the underwriter may elect to exercise all or part of the over-allotment option. The underwriter
may also elect to stabilize the price of our shares or reduce any short position by bidding for, and purchasing, shares of common
stock in the open market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The underwriter may also impose a penalty
bid. This occurs when an underwriter or dealer repays selling concessions allowed to it for distributing a security in this offering
because the underwriter repurchases that security in stabilizing or short covering transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Finally, the underwriter may bid for, and
purchase, our shares of common stock in market making transactions, including &#8220;passive&#8221; market making transactions
as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These activities may stabilize or maintain
the market price of our shares of common stock at a price that is higher than the price that might otherwise exist in the absence
of these activities. The underwriter is not required to engage in these activities, and may discontinue any of these activities
at any time without notice. These transactions may be effected on the Nasdaq Capital Market, in the over-the-counter market, or
otherwise and, if commenced, may be discontinued at any time. Neither we nor the underwriter make any representation or prediction
as to the effect that the transactions described above may have on the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with this offering, the underwriter
and selling group members, if any, or their affiliates may engage in passive market making transactions in our shares of common
stock immediately prior to the commencement of sales in this offering, in accordance with Rule 103 of Regulation M under the Securities
Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;). Rule 103 generally provides that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#9679; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a passive market maker may not
effect transactions or display bids for our shares of common stock in excess of the highest independent bid price by persons who
are not passive market makers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#9679; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;net purchases by a passive market
maker on each day are limited to a percentage of the passive market maker&#8217;s average daily trading volume in our shares of
common stock during a specified prior period, and must be discontinued when the limit is reached; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#9679;  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;passive market making bids must
be identified as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Electronic Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The prospectus and the prospectus supplement
in electronic format may be made available on internet sites or through other online services maintained by the underwriter, or
by its affiliates. In those cases, prospective investors may view offering terms online and, depending upon the underwriter, prospective
investors may be allowed to place orders online. The underwriter may agree with us to allocate a specific number of shares for
sale to online brokerage account holders. Any such allocation for online distributions will be made by the underwriter on the same
basis as other allocations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Other than the prospectus and the prospectus
supplement in electronic format, the information on the underwriter&#8217;s website and any information contained in any other
website maintained by the underwriter is not part of this prospectus supplement, the accompanying prospectus or the registration
statement of which this prospectus supplement and the accompanying prospectus form a part, has not been approved and/or endorsed
by us or the underwriter in its capacity as underwriter and should not be relied upon by investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The compensation to be paid to the underwriter
in connection with this offering is limited to the fees and expenses described above under &#8220;Underwriting Discount and Expenses.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_09"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The validity of the issuance of the securities
offered hereby will be passed upon for us by Mitchell Silberberg &amp; Knupp, LLP, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_10"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The consolidated financial statements of
ClearSign Technologies Corporation incorporated into this prospectus supplement by reference to our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920039929/tm205247d1_10k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K for the year ended December 31, 2019</A> for each of the years in the two&#45;year period ended December 31, 2019 have
been audited by Gumbiner Savett Inc., independent registered public accounting firm, and are incorporated by reference in reliance
upon their report dated March 30, 2020, given on their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_11"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have filed with the SEC a registration
statement on Form S-3 under the Securities Act, with respect to the securities covered by this prospectus supplement. This prospectus
supplement, which is a part of the registration statement, does not contain all of the information set forth in the registration
statement or the exhibits and schedules filed therewith. For further information with respect to us and the securities covered
by this prospectus supplement, please see the registration statement and the exhibits filed with the registration statement. The
SEC maintains an internet website that contains reports, proxy and information statements and other information regarding registrants
that file electronically with the SEC. The address of the website is http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the information and periodic
reporting requirements of the Exchange Act, and, in accordance therewith, we file periodic reports, proxy statements and other
information with the SEC. Such periodic reports, proxy statements and other information are available for inspection and copying
at the website of the SEC referred to above. We maintain a website at http://www.clearsign.com. You may access our Annual Reports
on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed pursuant to Sections
13(a) or 15(d) of the Exchange Act with the SEC free of charge at our website as soon as reasonably practicable after such material
is electronically filed with, or furnished to, the SEC. Our website and the information contained on that site, or connected to
that site, are not incorporated into and are not a part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_12"></A>INFORMATION INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC permits us to &#8220;incorporate
by reference&#8221; the information contained in documents we file with the SEC, which means that we can disclose important information
to you by referring you to those documents rather than by including them in this prospectus supplement. Information that is incorporated
by reference is considered to be part of this prospectus supplement and you should read it with the same care that you read this
prospectus supplement. We have filed with the SEC, and incorporate by reference in this prospectus supplement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920039929/tm205247d1_10k.htm" STYLE="-sec-extract: exhibit">our Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the SEC on March 30, 2020</A>;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the information specifically incorporated by reference into our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920039929/tm205247d1_10k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K for the year ended December 31, 2019</A> from our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920051312/tm205247-4_def14a.htm">Definitive Proxy Statement on Schedule 14A for our 2020 Annual Meeting of Shareholders, as filed with the SEC on April 27, 2020</A>;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our Quarterly Reports on Form 10-Q for the quarters ended March 31,
2020 and June 30, 2020 as filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920061692/tm2014540-1_10q.htm">May 14, 2020</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920095507/tm2020537d1_10q.htm">August 14, 2020</A>, respectively;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our Current Reports on Form 8-K as filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920004160/tm203457d1_8k.htm">January 15, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920005132/tm203755d1_8k.htm">January 17, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920023404/tm209560d1_8k.htm">February 20, 2020</A> (other than information furnished not filed), <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920048267/tm2016278d1_8k.htm">April 17, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920075656/tm2023112-1_8k.htm">June 22, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920079415/tm2023882-1_8k.htm">July 1, 2020</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000110465920083131/tm2024685d1_8k.htm">July 13, 2020</A>; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420412023200/v310160_8a12b.htm">the description of our common stock in our registration statement on Form 8-A filed with the SEC on April 23, 2012, including all amendments and reports filed for the purpose of updating such description.</A></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, all documents filed by us
with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than any portions of filings that are furnished
rather than filed pursuant to Items 2.02 and 7.01 of a Current Report on Form 8-K), after the date of this prospectus supplement
and before the termination or completion of this offering shall be deemed to be incorporated by reference into this prospectus
supplement from the respective dates of filing of such documents. Any information that we subsequently file with the SEC that is
incorporated by reference as described above will automatically update and supersede any previous information that is part of this
prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are not, however, incorporating, any
documents or information that we are deemed to furnish and not file in accordance with SEC rules. We maintain a website at www.clearsign.com.
The information on our website is not considered part of or incorporated by reference in this prospectus or any other document
we file with or furnish to the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon written or oral request, we will provide
you without charge, a copy of any or all of the documents incorporated by reference, other than exhibits to those documents unless
the exhibits are specifically incorporated by reference in the documents. Please send requests to ClearSign Technologies Corporation,
12870 Interurban Avenue South, Seattle, Washington 98168, Attn: Chief Financial Officer, Telephone: (206) 673-4848.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<FONT STYLE="font-family: Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm2028978-1_424b2img002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$50,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities, Common Stock, Preferred
Stock, Warrants,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Units, and Subscription Rights Offered
by</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ClearSign Combustion Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">By this prospectus
and an accompanying prospectus supplement, we may from time to time offer and sell, in one or more offerings, up to $50,000,000
in any combination of debt securities, common stock, preferred stock, warrants, units, or subscription rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We will provide
you with more specific terms of the securities offered by us in one or more supplements to this prospectus. You should read this
prospectus and the applicable prospectus supplement carefully before you invest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may offer these
securities from time to time in amounts, at prices and on other terms to be determined at the time of offering. We may offer and
sell these securities to or through underwriters, dealers or agents, or directly to investors, on a continuous or delayed basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The supplements
to this prospectus will provide the specific terms of the plan of distribution. The price to the public of the securities we offer
and the net proceeds we expect to receive from such sale will also be set forth in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Our common
stock is listed on the Nasdaq Capital Market under the symbol &ldquo;CLIR&rdquo;. On June 25, 2019, the closing price of our
common stock as reported by the Nasdaq Capital Market was $1.0947 per share. The aggregate market value of our outstanding
voting common stock held by non-affiliates, based upon a closing sale price of our common stock on June 25, 2019, was
$23,403,762. During the 12 calendar month period that ends on, and includes, the date of this prospectus, we have not
offered any securities pursuant to General Instruction I.B.6. of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><B><I>An investment
in our securities may be considered speculative and involves a high degree of risk, including the risk of a substantial loss of
your investment. See &ldquo;Risk Factors&rdquo; on page 7 for more information on the risks you should consider before buying our
securities. An investment in our securities is not suitable for all investors. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities, or passed upon the adequacy or accuracy of
this prospectus.&nbsp; Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is July 12,
2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%; text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">MARKET, INDUSTRY AND OTHER DATA</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">2</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">OUR BUSINESS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">DILUTION</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">DESCRIPTION OF SECURITIES THAT MAY BE OFFERED</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">8</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">Description
of Debt Securities</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">8</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">Description
of Common Stock</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">15</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">Description
of Preferred Stock</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">18</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">Description
of Warrants</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">18</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">Description
of Units</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">19</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom; padding-left: 10pt"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">Description
of Subscription Rights</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">20</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">21</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_016"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_016"><FONT STYLE="font-size: 10pt">23</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_017"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_017"><FONT STYLE="font-size: 10pt">23</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_018"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_018"><FONT STYLE="font-size: 10pt">23</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: bottom"><A HREF="#a_019"><FONT STYLE="font-size: 10pt">INFORMATION INCORPORATED BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><A HREF="#a_019"><FONT STYLE="font-size: 10pt">24</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus is part of a registration
statement filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) using a &ldquo;shelf&rdquo; registration process.
Under this shelf process, we may sell the securities described in this prospectus in one or more offerings. This prospectus provides
you with a general description of the securities that may be offered. Each time we offer securities for sale, we will provide a
prospectus supplement that contains specific information about the terms of that offering. Any prospectus supplement may also add
or update information contained in this prospectus. You should read both this prospectus and any prospectus supplement together
with additional information described below under &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Information Incorporated
by Reference.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The registration statement that contains
this prospectus (including the exhibits thereto) contains additional important information about us and the securities we may offer
under this prospectus. Specifically, we have filed certain legal documents that establish the terms of the securities offered by
this prospectus as exhibits to the registration statement. We will file certain other legal documents that establish the terms
of the securities offered by this prospectus as exhibits to reports we file with the SEC. You may obtain copies of the registration
statement and the other reports and documents referenced herein as described below under the heading &ldquo;Where You Can Find
More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should rely only on the information
contained or incorporated by reference in this prospectus and in any prospectus supplement. We have not authorized any other person
to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely
on it. We are not making offers to sell or solicitations to buy the securities in any jurisdiction in which an offer or solicitation
is not authorized or in which the person making that offer or solicitation is not qualified to do so or to anyone to whom it is
unlawful to make an offer or solicitation. You should not assume that the information in this prospectus or any prospectus supplement,
as well as the information we file or previously filed with the SEC that we incorporate by reference in this prospectus or any
prospectus supplement, is accurate as of any date other than the date of such document. Our business, financial condition, results
of operations and prospects may have changed since those dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In this prospectus, unless the context otherwise
requires, references to &ldquo;ClearSign,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; or the &ldquo;Company&rdquo;
refer to ClearSign Combustion Corporation and its subsidiary, ClearSign Asia Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_002"></A>MARKET,
INDUSTRY AND OTHER DATA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus, including the information
incorporated by reference, contains estimates, projections and other information concerning our industry, our business, and the
markets for certain products and services, including data regarding the estimated size of those markets and their projected growth
rates. Information that is based on estimates, forecasts, projections or similar methodologies is based on a number of assumptions
and is inherently subject to uncertainties, including those described in &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus
and documents incorporated by reference in this prospectus, and actual events or circumstances may differ materially from events
and circumstances reflected in this information. You are cautioned not to give undue weight to such estimates, projections and
other information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>DISCLOSURE REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus and any accompanying prospectus
supplement, including the documents that we incorporate by reference, may contain forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and Section 21E of the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Forward-looking statements in this prospectus
and any accompanying prospectus supplement include, without limitation, statements related to our plans, strategies, objectives,
expectations, intentions and adequacy of resources. Investors are cautioned that such forward-looking statements involve risks
and uncertainties. Factors that could cause actual results to differ from those discussed in the forward-looking statements include,
but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">our limited cash and our history of losses;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">our ability to successfully develop and implement our technology and achieve profitability;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">our limited operating history;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">changes in government regulations that could substantially reduce, or even eliminate, the need for our technology;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">emerging competition and rapidly advancing technology in our industry that may outpace our technology;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">customer demand for the products and services we develop;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the impact of competitive or alternative products, technologies and pricing;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">our ability to manufacture any products we design;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">general economic conditions and events and the impact they may have on us and our potential customers;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">our ability to obtain adequate financing in the future;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">our ability to continue as a going concern;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">our success at managing the risks involved in the foregoing items; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">other factors discussed in this prospectus.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In some cases, you can identify forward-looking
statements by terminology such as &lsquo;&lsquo;may,&rsquo;&rsquo; &lsquo;&lsquo;will,&rsquo;&rsquo; &lsquo;&lsquo;should,&rsquo;&rsquo;
&lsquo;&lsquo;could,&rsquo;&rsquo; &lsquo;&lsquo;expects,&rsquo;&rsquo; &lsquo;&lsquo;plans,&rsquo;&rsquo; &lsquo;&lsquo;intends,&rsquo;&rsquo;
&lsquo;&lsquo;anticipates,&rsquo;&rsquo; &lsquo;&lsquo;believes,&rsquo;&rsquo; &lsquo;&lsquo;estimates,&rsquo;&rsquo; &lsquo;&lsquo;predicts,&rsquo;&rsquo;
&lsquo;&lsquo;potential,&rsquo;&rsquo; or &lsquo;&lsquo;continue&rsquo;&rsquo; or the negative of such terms or other comparable
terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee
future results, levels of activity, performance or achievements. Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. We do not undertake any obligation to publicly update or review any forward-looking
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 22; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>OUR BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>This is only a summary and may not contain
all the information that is important to you. You should carefully read both this prospectus and any accompanying prospectus supplement
and any other offering materials, together with the additional information described under the heading &ldquo;Where You Can Find
More Information.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>About ClearSign Combustion Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We design and develop technologies that
have been shown to significantly improve key performance characteristics of combustion systems, including emission and operational
performance, energy efficiency and overall cost-effectiveness. We believe that our patented Duplex&trade; technology can enhance
the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and down-stream
refining), institutional commercial and industrial boiler, chemical, and petrochemical industries. Our Duplex technology, which
is our primary technology, uses a porous ceramic matrix at a distance to a burner to significantly reduce flame length and achieve
very low emissions without the need for external flue gas recirculation, selective catalytic reduction, or excess air systems.
To date, our operations have been funded primarily through sales of our equity securities. We have earned nominal revenue since
inception in 2008.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Duplex has been successfully installed in
commercial projects across four different combustion applications. Based on the results of our testing and initial field installations,
we believe that Duplex is more effective and cost-efficient than current industry-standard air pollution control technologies,
such as selective catalytic reduction devices, low- and ultra-low NOx burners (which address nitrogen oxides or NOx), external
flue gas recirculation systems and other similar technologies. Such systems are used in our current target market segments of petroleum
refining and petrochemical process heaters, large-scale once through steam generators (OTSGs), enclosed flares, institutional commercial
and industrial boilers and other similar equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the limited operating data we have
obtained from installations, burners utilizing ClearSign&rsquo;s ceramic Duplex technology provide increased heat transfer efficiency
compared to standard burner designs. This is consistent with the physics of heat transfer and the mechanisms by which the ceramic
technology functions. The increased heat transfer efficiency as reported results in cost savings in the low to mid-single digit
range which produces an extremely attractive pay-back period for an investment in ClearSign technology-based burners. In addition,
since the flames in a Duplex system are established within the confines of a ceramic enclosure and form with minimal &ldquo;bulking
up&rdquo; from dilutive inert flue gasses, the flame volumes are small, thus virtually eliminating flame impingement and enabling
the burners to function better in tightly spaced heaters. As a result, heaters utilizing ClearSign technology require less maintenance,
operate at a lower cost, have increased productivity when heater operation is otherwise constrained by the internal furnace volume,
and, more importantly, have decreased process downtime.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Industry</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The combustion and emissions control markets
are significant, both in the wide array of industries in which the systems are used and in the amount of money spent in installing
and upgrading systems. Combustion systems are used to provide heat for all manner of industrial processes, including boilers, furnaces,
kilns and gas turbines. In order to maximize energy efficiency while keeping pace with regulatory guidelines for air pollution
emissions, operators of combustion systems are continually installing, maintaining and upgrading a variety of costly process control,
air pollution control and monitoring systems. Although we believe that there are many potential markets for our Duplex technology,
to date we have prioritized the introduction of Duplex to petroleum refining process heaters, steam generation, district heating
and enclosed flares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Proprietary Technology</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Duplex burner technology consists of
an industrial burner body and a downstream porous ceramic matrix. When the unreacted mix of gaseous fuel and air is directed at
the ceramic matrix, the mixture ignites and stabilizes within the matrix itself. Because the fuel and air have more time to mix,
the homogeneous mixture mitigates NOx-forming hot spots and chemistry that are typically produced. The mixing and combustion in
the ceramic matrix results in a dramatically shorter flame, and modification of the matrix enables a high level of control over
the shape of the flame allowing it to be optimized for a wide range of different applications. NOx, a regulated greenhouse gas
pollutant comprised largely of nitrogen oxide and nitrogen dioxide, is greatly reduced to levels of 5ppm or below, depending on
the specific application, without any external fans or associated power, thereby minimizing harmful emissions while improving system
efficiency. A shorter flame can often allow for operation of the furnace at a higher capacity. We believe Duplex&rsquo;s radiant
heat transfer from the ceramic matrix enhances thermal efficiency, minimizes the possibility of flame impingement and reduces the
likelihood of carbon deposits forming on the inside surfaces of the process tubes (coking) or failure of process tubes extending
the length of time a heater can remain in operation before the need for maintenance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Duplex Plug &amp; Play&reg; product
provides a more simplified, pre-engineered and standardized direct burner replacement for traditional refinery process heaters.
We believe that this product will reduce the customized engineering associated with typical retrofits and lend itself to mass production.
The product derives its name from the fact that it is designed to allow quick and easy installation into a multi-burner heater
or furnace and possibly allow the heater to continue operating during installation rather than be shut down. The ability to install
the Duplex Plug &amp; Play while the remaining burner system is operational will allow customers to limit down time and shorten
the sales cycle often prolonged by annual or semi-annual scheduled maintenance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To date, we have deployed our Duplex technology
through retrofits and replacements of existing burners and complete replacement units in the case of our Plug &amp; Play products.
Retrofits often involve engineering around an existing burner architecture that can complicate the Duplex installation, whereas
replacements are more straightforward and more amenable to being sold and installed by third parties, enabling more expansive channels
to market. This is especially the case after the introduction of our Duplex Plug &amp; Play technology in February 2017 and simplified
control and operation in April 2019. Because of this, we have focused the development of our technology to provide designs that
can be included into our customers&rsquo; equipment as self-contained modules or assemblies rather than as individual projects
involving the re-engineering of existing burner systems. In this form, we believe that ClearSign burner technology is ideally suited
for installation into new heaters and burner replacement markets, including heater and furnace types requiring large quantities
of burners. We have also developed flare and boiler burner technology into a similar repeatable form to aid its inclusion in standard
industry equipment on a commercial scale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For simplification and marketing, we have
adopted the term &ldquo;ClearSign Core<FONT STYLE="font-family: Symbol">&auml;</FONT>&rdquo; to refer to the inclusion of this
standardized Duplex technology into a variety of combustion systems including, but not limited to, burners, furnaces, boilers,
heaters, thermal oxidizers and flares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have now achieved emission results in
multiple applications that were superior to current local Best Available Control Technology (BACT) levels in multiple installations
in California related to three of our five target industries. We intend to continue to demonstrate Duplex capabilities through
(i) working with local air quality officials to demonstrate the effectiveness of the technology, (ii) operating in-place units,
(iii) engineering and testing with new customers and applications, (iv) pursuing additional lab research and development of new
applications (e.g. institutional commercial and industrial boilers) and next generation improvements to Duplex design and standardization,
including the pursuit of more complete systems similar to the Duplex Plug &amp; Play for application in other vertical markets,
and (v) assisting our customers in making emission results available for designation as BACT by local regulatory bodies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Business Model and Monetization Strategy</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As described above, we have developed our
Duplex technology into standardized configurations that can be incorporated into equipment sold by the major vendors in the industry
in an effort to gain quick access to our large global markets and that for brand recognition and marketing purposes, we have named
the inclusion of our technology into OEM equipment as the &ldquo;ClearSign Core<FONT STYLE="font-family: Symbol">&auml;</FONT>.
This approach allows us to sell our technology business to business, through an arrangement similar to a license, to selected alliance
companies which then manufacture and deliver the complete equipment to the final customers. The objective of this business model
is to enable ClearSign to leverage our technology and the vast resources and networks of our supply partners to sell to the global
markets. The details of such collaborative agreements will vary depending on the nature of the individual markets and requirements
to achieve an optimum collaboration with our partners. At this time, we have entered into one such agreement and have received
demonstrated interest in collaboration from other major equipment suppliers in all major verticals and target markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our Target Markets</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We compete in the combustion and emissions
control markets. These are highly competitive industries that are currently dominated by companies that have both substantially
greater infrastructure, customer support networks, and financial resources than we do as well as established products. Based on
the testing and the field installations completed to date, however, we believe that our Duplex technology provides a unique and
powerful ability to improve energy efficiency and operational performance, while at the same time significantly reducing emissions,
leading to an overall cost-effective installation. Further, we believe that the ClearSign burner technology is well suited to create
substantial synergistic value through its incorporation into the mainstream commercial offerings of the market incumbents as a
&ldquo;ClearSign Core,&rdquo; thus leveraging the ClearSign technology and the established breadth and capabilities of collaborating
companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are targeting the following segments
of the combustion market:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">institutional commercial and industrial
boiler segment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">refinery and petrochemical segment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">large industrial segment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">enclosed flare segment; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">enhanced oil recovery segment</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In each segment, we are marketing solutions
with our Duplex technology that we believe could simultaneously improve both operational efficiency and pollution control characteristics
through (a) cost-effective retrofitting of our Duplex technology into existing standard system designs, and (b) new system designs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our target markets are greatly affected
by air emission regulations and economic conditions, including the price and profitability related to crude oil and its processing.
We believe that operators in all of our target markets are under intense pressure to meet current and proposed federal, state and
local emissions standards. The standards applicable to our target markets have been developed over the past 50 years with broad
political input. Due to the localized effects of poor air quality, we anticipate these standards to continue regardless of national
political leadership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; color: #222222"><FONT STYLE="background-color: white">Emissions
standards in the United States largely emanate from the Clean Air Act, which is administered by the Environmental Protection Agency
(EPA) and regulates six common criteria air pollutants, including ground-level ozone. These regulations are enforced by state and
local air quality districts as part of their compliance plans. As a precursor to ground-level ozone, NOx is a regulated pollutant
by local air quality districts in order to achieve the EPA limits. The 8-hour ground-level ozone regulations have been reduced
from 84 parts per billion (ppb) in 1997, to 75 ppb in 2008, and 70 ppb in 2015, with the requirement of realizing these levels
approximately 25 years following the year of legislation. The areas of non-attainment related to this 1997 limit of 84 ppb are
depicted below in the map on the left and the projected areas of non-attainment related to the 2015 limit of 70 ppb are depicted
below in the map on the right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: center"><FONT><IMG SRC="tm2028978-1_424b2img003.jpg" ALT="">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: center"><FONT STYLE="font-size: 10pt; color: #222222; background-color: white"><IMG SRC="tm2028978-1_424b2img004.jpg" ALT="">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #222222"><I>Non-attainment areas under the 1997 limit of 84 ppb  Source: EPA, August 2016</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt; color: #222222"><I>Projected non-attainment areas under the 2015 limit of 70 ppb Source:
    URS, August 2015</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, we believe that current emissions
standards in Europe, China, the Middle East, other parts of Asia and Canada will continue to trend towards stricter air emission
standards as these jurisdictions seek to achieve cleaner air. Existing and new emissions standards in such jurisdictions may create
additional market opportunities for us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Additional Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For a description of our business, financial
condition, results of operations and other important information regarding us, we refer you to our filings with the SEC incorporated
by reference in this prospectus supplement. For instructions on how to find copies of these documents, see &ldquo;Where You Can
Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our facilities and executive offices are
located at 12870 Interurban Avenue South, Seattle, Washington 98168, and our telephone number is (206) 673-4848. We were incorporated
in Washington on January 23, 2008. Additional information about us is available on our website at www.clearsign.com. The information
contained on or that may be obtained from our website is not, and shall not be deemed to be, a part of this prospectus. Our common
stock, par value $0.0001 per share, is currently traded on the Nasdaq Capital Market under the ticker symbol &ldquo;CLIR.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="a_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investing in our common
stock involves a high degree of risk. Please see the risk factors set forth below and in Part I, Item 1A of our Annual Report
on Form 10-K and Part II, Item 1A of our Quarterly Reports on Form 10-Q and other filings we make with the SEC, which are
incorporated by reference in this prospectus. Additional risk factors may be included in a prospectus supplement relating to
a particular offering of securities. Before making an investment decision, you should carefully consider these risks as well
as other information we include or incorporate by reference in this prospectus. These risks could materially affect our
business, results of operations or financial condition and cause the value of our securities to decline.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>A cybersecurity incident or other technology disruptions
could negatively impact our business and our relationships with customers.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We use computers in substantially all aspects
of our business operations. We also use mobile devices and other online activities to connect with our employees, suppliers and
customers. Such uses give rise to cybersecurity risks, including security breaches, espionage, system disruption, theft, the compromise
of trade secrets and inadvertent release of information. Our business involves the storage and transmission of sensitive and/or
confidential information and intellectual property, including customers&rsquo; and suppliers&rsquo; information, private information
about employees and financial and strategic information about us. If we fail to assess and identify cybersecurity risks associated
with our operations, we may become increasingly vulnerable to such risks. Additionally, while we have implemented measures to prevent
security breaches and cyber incidents, our preventative measures and incident response efforts may not be entirely effective. The
theft, destruction, loss, misappropriation, or release of sensitive and/or confidential information or intellectual property, or
interference with our information technology systems, could result in business disruption, negative publicity, brand damage, violation
of privacy laws, loss of customers, potential liability and competitive disadvantage all of which could have a material adverse
effect on our business, financial condition or results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless we state otherwise in an accompanying
prospectus supplement, we intend to use the net proceeds from the sale of the securities offered by us under this prospectus and
any related prospectus supplement for general corporate purposes. These purposes may include capital expenditures, acquisitions
and additions to working capital. When a particular offering of securities is made, the prospectus supplement relating to that
offering will set forth our intended use of the net proceeds we receive from the sale of the securities. Pending the application
of the net proceeds, we may invest the proceeds in short-term, interest-bearing instruments or other investment-grade securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">With the exception of debt securities
we may sell with no equity conversion feature and, therefore, no effect on dilution, we will set forth in a prospectus
supplement the following information regarding any material dilution of the equity interests of investors purchasing
securities sold by ClearSign in an offering under this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the net tangible book value per share of our equity securities before and after the offering;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the amount of the increase in such net tangible book value per share attributable to the cash payments made by purchases in
the offering; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the amount of the immediate dilution from the public offering price which will be absorbed by such purchasers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>DESCRIPTION OF THE SECURITIES THAT MAY
BE OFFERED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>Description of Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description, together with
the additional information we include in any applicable prospectus supplement, summarizes certain general terms and provisions
of the debt securities that we may offer under this prospectus. When we offer to sell a particular series of debt securities, we
will describe the specific terms of the series in a supplement to this prospectus. The supplement will also indicate to what extent
the general terms and provisions described in this prospectus apply to a particular series of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may issue debt securities, either separately,
or together with, or upon the conversion or exercise of or in exchange for, other securities described in this prospectus. Debt
securities may be our senior, senior subordinated or subordinated obligations, issued in one or more series, and, unless otherwise
specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The debt securities will be issued under
an indenture between us and a trustee to be identified in the applicable prospectus supplement. We have summarized select portions
of the indenture below. Please note, however, that the summary below is not complete. The form of the indenture has been filed
as an exhibit to the registration statement of which this prospectus forms a part and you should read the indenture for provisions
that may be important to you. Capitalized terms used in the summary below and not defined herein have the meanings specified in
the form of the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>General</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The terms of each series of debt securities
will be established by or pursuant to a resolution of our board of directors and set forth or determined in the manner provided
in a resolution of our board of directors, in an officer&rsquo;s certificate, or by a supplemental indenture. The particular terms
of each series of debt securities will be described in a prospectus supplement relating to such series (including any pricing supplement
or term sheet).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We can issue an unlimited amount of debt
securities under the indenture that may be in one or more series with the same or various maturities, at par, at a premium, or
at a discount. The prospectus supplement (including any pricing supplement or term sheet) relating to any series of debt securities
being offered will set forth the aggregate principal amount and the other terms of the debt securities, including, if applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the title and ranking of the debt securities (including the terms of any subordination provisions);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the price or prices at which the debt securities will be sold;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any limit on the aggregate principal amount of the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the date or dates on which the principal of and premium, if any, on the debt securities is payable and/or the method of determination
thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates (including any
commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date
or dates from which interest will accrue, the date or dates on which interest will commence and be payable and any regular record
date for the interest payable on any interest payment date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the place or places where principal of, and interest, if any, on the debt securities will be payable (and the method of such
payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and
demands to us in respect of the debt securities may be delivered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the right, if any, to extend the interest payment periods and the duration of such extension;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the period or periods within which, the price or prices at which, and the terms and conditions upon which, we may redeem the
debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any obligation we will have to redeem or purchase the debt securities pursuant to any sinking fund or analogous provisions
(including payments made in cash in participation of future sinking fund obligations) or at the option of a holder of debt securities,
and the period or periods within which (or manner of determining the same), the price or prices at which (or manner of determining
the same), and the terms and conditions upon which, debt securities of the series shall be redeemed or purchased, in whole or in
part, pursuant to such obligation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the dates on which, and the price or prices at which, we will repurchase debt securities at the option of the holders of debt
securities and other detailed terms and provisions of these repurchase obligations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the form of the debt securities of the series, including the form of the trustee&rsquo;s certificate of authentication for
such series and any legends or endorsements to be placed thereon;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple
thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>whether the debt securities will be issued in the form of certificated debt securities or global debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other
than the principal amount;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the currency of denomination of the debt securities, which may be United States dollars or any foreign currency, and if such
currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite
currency;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the designation of the currency, currencies or currency units in which payment of principal of, premium, if any, and
                                                                                                               interest                                                                                                                on
                                                                                                               the debt securities will be made;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if payments of principal of, or premium, if any, or interest on the debt securities will be made in one or more currencies
or currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate
with respect to these payments will be determined;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities will be determined,
if these amounts may be determined by reference to an index based on a currency or currencies other than that in which the debt
securities are denominated or designated to be payable or by reference to a commodity, commodity index, stock exchange index or
financial index;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any provisions relating to any security provided for the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture with respect
to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect
to the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any addition to, deletion of or change in the covenants described in this prospectus or set forth in the indenture with respect
to the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the provisions, if any, relating to conversion or exchange of any debt securities of such series, including if applicable,
the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory, the events requiring
an adjustment of the conversion or exchange price and provisions affecting conversion or exchange;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if other than the trustee, the identity of the trustee, the registrar, paying agent and custodian for the depositary;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if other than The Depository Trust Company, the identity of the depositary; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as it applies
to that series, including any terms that may be required under applicable law or regulations or advisable in connection with the
marketing of the securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may issue debt securities that provide
for an amount less than their stated principal amount to be due and payable upon declaration of acceleration of their maturity
pursuant to the terms of the indenture. Information on the federal income tax considerations and other special considerations applicable
to any of these debt securities will be provided in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the purchase price of any of the debt
securities is denominated in a foreign currency or currencies or a foreign currency unit or units, or if the principal of and any
premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit
or units, then information on the restrictions, elections, general tax considerations, specific terms and other information with
respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units will be provided
in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Transfer and Exchange</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each debt security will be represented by
either one or more global securities registered in the name of The Depository Trust Company (which we refer to as &ldquo;DTC&rdquo;)
or a nominee of DTC (which we refer to as a &ldquo;book-entry debt security&rdquo;), or a certificate issued in definitive registered
form (which is referred to as a &ldquo;certificated debt security&rdquo;), as set forth in the applicable prospectus supplement.
Except as set forth under the heading &ldquo;Global Debt Securities and Book-Entry System&rdquo; below, book-entry debt securities
will not be issuable in certificated form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Certificated Debt Securities</I></B>.
Holders may transfer or exchange certificated debt securities at any office we maintain for this purpose in accordance with the
terms of the indenture. No service charge will be made for any transfer or exchange of certificated debt securities, but payment
of a sum sufficient to cover any tax or other governmental charge payable in connection with a transfer or exchange may be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders may effect the transfer of certificated
debt securities and the right to receive the principal of, or any premium or interest on, certificated debt securities only by
surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the
certificate to the new holder or the issuance by us or the trustee of a new certificate to the new holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Global Debt Securities and Book-Entry
System</I></B>. Each global debt security representing book-entry debt securities will be deposited with, or on behalf of, DTC,
and registered in the name of DTC or a nominee of DTC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Covenants</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any restrictive covenants applicable to
any issue of debt securities will be set forth in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>No Protection in the Event of a Change of Control</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless stated otherwise in the applicable
prospectus supplement, the debt securities will not contain any provisions that may afford holders of the debt securities protection
in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results
in a change in control) that could adversely affect holders of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Consolidation, Merger and Sale of Assets</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may not consolidate with or merge with
or into, or convey, transfer or lease all or substantially all of our properties and assets to any person (a &ldquo;successor person&rdquo;)
unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we are the surviving corporation or the successor person (if other than us) is a corporation that is organized and validly
existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under
the indenture; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>immediately after giving effect to the transaction, no Default or Event of Default shall have occurred and be continuing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding the above, our subsidiaries
may consolidate with, merge into, or transfer all or part of its properties to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Events of Default</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;Event of Default&rdquo; means with
respect to any series of debt securities, any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>default in the payment of any interest upon any debt security of that series when it becomes due and payable, and continuance
of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a
paying agent prior to the expiration of the 30-day period;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>default in the payment of principal of any security of that series when it becomes due and payable, whether at stated maturity,
upon redemption, upon purchase, upon acceleration or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>default in the performance or breach of any other covenant or warranty by us in the indenture (other than a covenant or warranty
that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default
continues uncured for a period of 60 days after we receive written notice from the trustee, or we and the trustee receive written
notice from the holders of not less than a majority in principal amount of the outstanding debt securities of that series as provided
in the indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any other Event of Default provided with respect to debt securities of that series that is described in the applicable prospectus
supplement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No Event of Default with respect to a particular
series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an
Event of Default with respect to any other series of debt securities. The occurrence of certain Events of Default or an acceleration
under the indenture may constitute an event of default under certain other of our indebtedness or indebtedness of our subsidiaries
outstanding from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">So long as any of the securities are outstanding,
we will provide the trustee written notice of any Default or Event of Default within 30 days of becoming aware of the occurrence
of such Default or Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an Event of Default with respect to debt
securities of any series at the time outstanding occurs and is continuing, then the trustee or the holders of not less than a majority
in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if
given by the holders), declare to be due and payable immediately the principal of (or, if the debt securities of that series are
discount securities, that portion of the principal amount as may be specified in the terms of that series) and accrued and unpaid
interest, if any, on all debt securities of that series. Such acceleration will not be effective until the earlier of (1) the acceleration
of indebtedness under our senior secured credit facilities or (2) five business days after receipt by us of written notice of such
acceleration, at which time the principal, premium, if any, interest and any other monetary obligations on all the then outstanding
series of debt securities will become due and payable immediately. In the case of an Event of Default resulting from certain events
of bankruptcy, insolvency or reorganization, the principal (or such specified amount) and accrued and unpaid interest, if any,
on all outstanding debt securities or the applicable series will become and be immediately due and payable without any declaration
or other act on the part of the trustee or any holder of outstanding debt securities. At any time after a declaration of acceleration
with respect to debt securities of any series has been made, but before a judgment or decree for payment of the money due has been
obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind
and annul the acceleration if all Events of Default, other than the non-payment of accelerated principal and interest, if any,
with respect to debt securities of that series, have been cured or waived as provided in the indenture. Please refer to the prospectus
supplement relating to any series of debt securities that are discount securities for the particular provisions relating to acceleration
of a portion of the principal amount of such discount securities upon the occurrence of an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The indenture will provide that the trustee
will be under no obligation to exercise any of its rights or powers under the indenture unless the trustee receives indemnity satisfactory
to it against any cost, liability or expense which might be incurred by it in exercising such right of power. Subject to certain
rights of the trustee, the holders of a majority in principal amount of the outstanding debt securities of any series will have
the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising
any trust or power conferred on the trustee with respect to the debt securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No holder of any debt security of any series
will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment of
a receiver or trustee, or for any remedy under the indenture, unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>that holder has previously given to the trustee written notice of a continuing Event of Default with respect to debt securities
of that series; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the holders of not less than a majority in principal amount of the outstanding debt securities of that series have made written
request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee,
and the trustee has not received from the holders of not less than a majority in principal amount of the outstanding debt securities
of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding any other provision in the
indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the principal of,
premium and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit
for the enforcement of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The indenture requires us, within 120 days
after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture. If a Default or Event
of Default occurs and is continuing with respect to the debt securities of any series and if it is known to a responsible officer
of the trustee, the trustee shall mail to each holder of the debt securities of that series notice of a Default or Event of Default
within 90 days after it occurs. The indenture provides that the trustee may withhold notice to the holders of debt securities of
any series of any Default or Event of Default (except in payment on any debt securities of that series) with respect to debt securities
of that series if the trustee determines in good faith that withholding notice is in the interest of the holders of those debt
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Modification and Waiver</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the trustee may modify, amend or
supplement the indenture or the debt securities of any series without the consent of any holder of any debt security:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to cure any ambiguity, defect or inconsistency;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to comply with covenants in the indenture described above under the heading &ldquo;Consolidation, Merger and Sale of Assets&rdquo;;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to provide for uncertificated securities in addition to or in place of certificated securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to make any change that does not adversely affect the rights of any holder of debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to provide for the issuance of and establish the form and terms and conditions of debt securities of any series as permitted
by the indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to add covenants for the benefit of the holders of debt securities of any series or to surrender any right or power conferred
upon the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to or change
any of the provisions of the indenture to provide for or facilitate administration by more than one trustee; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture
Act of 1939, as amended.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may also modify and amend the indenture
with the consent of the holders of at least a majority in principal amount of the outstanding debt securities of each series affected
by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each affected
debt security then outstanding if that amendment will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reduce the rate of or extend the time for payment of interest (including default interest) on any debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of, or postpone
the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>reduce the principal amount of discount securities payable upon acceleration of maturity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>waive a default in the payment of the principal, premium or interest on any debt security (except a rescission of acceleration
of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding
debt securities of that series and a waiver of the payment default that resulted from such acceleration);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>make the principal of or premium or interest on any debt security payable in currency other than that stated in the debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>make any change to certain provisions of the indenture relating to, among other things, the right of holders of debt securities
(i) to receive payment of the principal, premium and interest on those debt securities, (ii) to institute suit for the enforcement
of any such payment, or (iii) to consent to an amendment or waiver in accordance with the requirements of the debenture; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>waive a redemption payment with respect to any debt security.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except for certain specified provisions,
the holders of at least a majority in principal amount of the outstanding debt securities of any series may, on behalf of the holders
of all debt securities of that series, waive compliance by us with provisions of the indenture. The holders of a majority in principal
amount of the outstanding debt securities of any series may, on behalf of the holders of all the debt securities of such series,
waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of
the principal of or any interest on any debt security of that series; provided, however, that the holders of a majority in principal
amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related
payment default that resulted from the acceleration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Defeasance of Debt Securities and Certain Covenants in
Certain Circumstances</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Legal Defeasance</I></B>. The indenture
provides that, unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged from any
and all obligations in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon
the deposit with the trustee, in trust, of money and/or U.S. government obligations or, in the case of debt securities denominated
in a single currency other than U.S. dollars, government obligations of the government that issued or caused to be issued such
currency, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient
in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment
of principal, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series
on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This discharge may occur only if, among
other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has been published
by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change
in the applicable United States federal income tax law, in either case to the effect that, and based thereon such opinion shall
confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal
income tax purposes as a result of the deposit, defeasance and discharge and will be subject to United States federal income tax
on the same amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge
had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Defeasance of Certain Covenants</I></B>.
The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, upon compliance
with certain conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>we may omit to comply with the covenant described under the heading &ldquo;Consolidation, Merger and Sale of Assets&rdquo;
and certain other covenants set forth in the indenture, as well as any additional covenants that may be set forth in the applicable
prospectus supplement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to the debt securities
of that series (&ldquo;covenant defeasance&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The conditions include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities denominated in a single
currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that,
through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the
opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment
of principal of, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series
on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that series will not
recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance
and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would
have been the case if the deposit and related covenant defeasance had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Covenant Defeasance and Events of
Default.</I></B> In the event we exercise our option to effect covenant defeasance with respect to any series of debt securities
and the debt securities of that series are declared due and payable because of the occurrence of any Event of Default, the amount
of money and/or U.S. government obligations or foreign government obligations on deposit with the trustee will be sufficient to
pay amounts due on the debt securities of that series at the time of their stated maturity but may not be sufficient to pay amounts
due on the debt securities of that series at the time of the acceleration resulting from the Event of Default. However, we shall
remain liable for those payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>No Personal Liability of Directors, Officers, Employees
or Stockholders</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of our past, present or future directors,
officers, employees or stockholders, as such, will have any liability for any of our obligations under the debt securities or the
indenture or for any claim based on, or in respect or by reason of, such obligations or their creation. By accepting a debt security,
each holder waives and releases all such liability. This waiver and release is part of the consideration for the issue of the debt
securities. However, this waiver and release may not be effective to waive liabilities under U.S. federal securities laws, and
it is the view of the SEC that such a waiver is against public policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Governing Law</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The indenture and the debt securities will
be governed by, and construed in accordance with, the laws of the State of New York without regard to conflict of law principles
that would result in the application of any law other than the law of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B><A NAME="a_010"></A>Description of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following summary of the rights of our
common stock is not complete and is subject to and qualified in its entirety by reference to our articles of incorporation and
bylaws, copies of which are included as exhibits to our registration statement on Form S-3, of which this prospectus forms a part.
See &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have 64,500,000 shares of capital stock
authorized under our articles of incorporation, consisting of 62,500,000 shares of common stock and 2,000,000 shares of preferred
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of June 25, 2019, we had 29,090,232 shares
of common stock issued and outstanding. Our authorized but unissued shares of common stock are available for issuance without further
action by our shareholders, unless such action is required by applicable law or the rules of The Nasdaq Stock Market or any other
stock exchange or automated quotation system on which our securities may become listed or traded. If the approval of our shareholders
is not so required, our board of directors may determine not to seek shareholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of our common stock are entitled
to such dividends as may be declared by our board of directors out of funds legally available for such purpose, subject to any
preferential dividend rights of any then outstanding preferred stock. The shares of common stock are neither redeemable nor convertible.
Holders of common stock have no preemptive or subscription rights to purchase any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each holder of our common stock is entitled
to one vote for each such share outstanding in the holder&rsquo;s name. No holder of common stock is entitled to cumulate votes
in voting for directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of our liquidation, dissolution
or winding up, the holders of our common stock are entitled to receive pro rata our assets which are legally available for distribution,
after payments of all debts and other liabilities and subject to the prior rights of any holders of preferred stock then outstanding.
All of the outstanding shares of our common stock are fully paid and non-assessable. The shares of common stock offered by this
prospectus will also be fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is listed on the Nasdaq
Capital Market under the symbol &ldquo;CLIR&rdquo;. On June 25, 2019, the last sale price of our common stock was $1.0947 per share.
The transfer agent and registrar for our common stock is VStock Transfer, LLC. Its address is <FONT STYLE="background-color: white">18
Lafayette Place, Woodmere,</FONT> New York 11598, and its telephone number is (212) 828-8436.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Anti-Takeover Effects of Certain Provisions of Washington
Law and Our Charter Documents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following is a summary of certain provisions
of Washington law, our articles of incorporation and our bylaws. This summary does not purport to be complete and is qualified
in its entirety by reference to the corporate law of Washington and our articles of incorporation and bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Effect of Washington Anti-Takeover Statute.</I>
We are subject to Chapter 23B.19 of the Revised Code of Washington, an anti-takeover law (the &ldquo;Anti-Takeover Statute&rdquo;).
In general, the Anti-Takeover Statute prohibits a target corporation from entering into a significant business transaction with
an acquiring person for a period of five years following the acquiring person&rsquo;s share acquisition unless</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the share acquisition is
exempt because it was inadvertently made and the acquiring person, as soon as practicable, divests himself of a sufficient amount
of the voting shares of the target corporation so that he is no longer the beneficial owner, directly or indirectly, of voting
shares entitled to cast votes comprising 10% or more of the voting power of the target corporation and would not have, at any
time during the five year period&nbsp;&nbsp;preceding the announcement date of the significant business transaction have been
an acquiring person but for the inadvertent acquisition,</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the significant business transaction or the purchase of shares made by the acquiring person is approved prior to the acquiring person&rsquo;s share acquisition time by a majority of the members of the board of directors of the target corporation; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">at or subsequent to the acquiring person&rsquo;s share acquisition time, the significant business transaction is approved by a majority of the members of the board of directors of the target corporation and approved at an annual or special meeting of shareholders, and not by written consent, by the affirmative vote of at least two-thirds of the votes entitled to be cast by the outstanding voting shares of the target corporation, except shares beneficially owned by or under the voting control of the acquiring person.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Anti-Takeover Statute generally defines
an &ldquo;acquiring person&rdquo; as a person or group of persons, other than the target corporation or a subsidiary of the target
corporation, who is the beneficial owner of voting shares entitled to cast votes comprising 10% or more of the voting power of
the target corporation; provided, however, that the term &ldquo;acquiring person&rdquo; does not include a person who (a) beneficially
owned voting shares entitled to cast votes comprising 10% or more of the voting power of the target corporation on March 23, 1988;
(b) acquired its voting shares of the target corporation solely by gift, inheritance, or in a transaction in which no consideration
is exchanged; (c) equals or exceeds the 10% threshold as a result of action taken solely by the target corporation, such as redemption
of shares, unless that person, by his own action, acquires additional shares of the target corporation; (d) beneficially owned
voting shares entitled to cast votes comprising 10% or more of the voting power of the target corporation prior to the time the
target corporation had a class of voting shares registered with the SEC pursuant to section 12 or 15 of the Securities Exchange
Act; or (e) beneficially owned voting shares entitled to cast votes comprising 10% or more of the voting power of the target corporation
prior to the time the target corporation amended its articles of incorporation to provide that the corporation shall be subject
to the provisions of this chapter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Anti-Takeover Statute defines a &ldquo;significant
business transaction&rdquo; as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">A merger, share exchange, or consolidation of a target corporation or a subsidiary of a target corporation with (i) an acquiring person, or (ii) any other domestic or foreign corporation which is, or after the merger, share exchange, or consolidation would be, an affiliate or associate of the acquiring person;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">A sale, lease, exchange, mortgage, pledge, transfer, or other disposition or encumbrance, whether in one transaction or a series of transactions, to or with an acquiring person or an affiliate or associate of an acquiring person of assets of a target corporation or a subsidiary of a target corporation (i) having an aggregate market value equal to 5% or more of the aggregate market value of all the assets, determined on a consolidated basis, of the target corporation, (ii) having an aggregate market value equal to 5% or more of the aggregate market value of all the outstanding shares of the target corporation, or (iii) representing 5% or more of the earning power or net income, determined on a consolidated basis, of the target corporation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The termination, while the corporation has an acquiring person and as a result of the acquiring person&rsquo;s acquisition of 10% or more of the shares of the corporation, of 5% or more of the employees of the target corporation or its subsidiaries employed in this state, whether at one time or over the five-year period following the share acquisition time;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The issuance, transfer, or redemption by a target corporation or a subsidiary of a target corporation, whether in one transaction or a series of transactions, of shares or of options, warrants, or rights to acquire shares of a target corporation or a subsidiary of a target corporation to or beneficially owned by an acquiring person or an affiliate or associate of an acquiring person except pursuant to the exercise of warrants or rights to purchase shares offered, or a dividend, distribution, or redemption paid or made pro rata to, all shareholders or holders of options, warrants, or rights to acquire shares of the target corporation, and except for involuntary redemptions permitted by the target corporation&rsquo;s charter or by the law of this state or the state of incorporation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(e)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The liquidation or dissolution of a target corporation proposed by, or pursuant to an agreement, arrangement, or understanding, whether or not in writing, with an acquiring person or an affiliate or associate of an acquiring person;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(f)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">A reclassification of securities, including, without limitation, any shares split, shares dividend, or other distribution of shares in respect of stock, or any reverse shares split, or recapitalization of a target corporation, or a merger or consolidation of a target corporation with a subsidiary of the target corporation, or any other transaction, whether or not with or into or otherwise involving an acquiring person, proposed by, or pursuant to an agreement, arrangement, or understanding, whether or not in writing, with an acquiring person or an affiliate or associate of an acquiring person, that has the effect, directly or indirectly, of increasing the proportionate share of the outstanding shares of a class or series of voting shares or securities convertible into voting shares of a target corporation or a subsidiary of the target corporation that is directly or indirectly owned by an acquiring person or an affiliate or associate of an acquiring person, except as a result of immaterial changes due to fractional share adjustments; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(g)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">A receipt by an acquiring person or an affiliate or associate of an acquiring person of the benefit, directly or indirectly, except proportionately as a shareholder of a target corporation, of loans, advances, guarantees, pledges, or other financial assistance or tax credits or other tax advantages provided by or through a target corporation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Finally, the Anti-Takeover Statute defines
a &ldquo;target corporation&rdquo; as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Every domestic corporation, if:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) The corporation has a class
of voting shares registered with the SEC pursuant to Section 12 or 15 of the Securities Exchange Act; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) The corporation&rsquo;s articles
of incorporation have been amended to provide that such a corporation shall be subject to the provisions of this chapter, if the
corporation did not have a class of voting shares registered with the SEC pursuant to section 12 or 15 of the Securities Exchange
Act on the effective date of that amendment; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Every foreign corporation required to register to transact business in the State of Washington pursuant to Chapter 23B.15 and Article 5 of Chapter 23.95 of the Revised Code of Washington, if:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) The corporation has a class
of voting shares registered with the SEC pursuant to section 12 or 15 of the Securities Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) The corporation&rsquo;s principal
executive office is located in the state;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iii) The corporation has: (A)
more than 10% of its shareholders of record resident in the state; or (B) more than 10% of its shares owned of record by state
residents; or (C) 1,000 or more shareholders of record resident in the state;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(iv) A majority of the corporation&rsquo;s
employees, together with those of its subsidiaries, are residents of the state or the corporation, together with its subsidiaries,
employs more than one thousand residents of the state; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v) A majority of the corporation&rsquo;s
tangible assets, together with those of its subsidiaries, measured by market value, are located in the state or the corporation,
together with its subsidiaries, has more than fifty million dollars&rsquo; worth of tangible assets located in the state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Our Charter Documents.</I> Our charter
documents include provisions that may have the effect of discouraging, delaying or preventing a change in control or an unsolicited
acquisition proposal that a shareholder might consider favorable, including a proposal that might result in the payment of a premium
over the market price for the shares held by our shareholders. Certain of these provisions are summarized in the following paragraphs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Effects of authorized but unissued common
stock and blank check preferred stock. </I>One of the effects of the existence of authorized but unissued common stock and undesignated
preferred stock may be to enable our board of directors to make more difficult or to discourage an attempt to obtain control of
our Company by means of a merger, tender offer, proxy contest or otherwise, and thereby to protect the continuity of management.
If, in the due exercise of its fiduciary obligations, the board of directors were to determine that a takeover proposal was not
in our best interest, such shares could be issued by the board of directors without shareholder approval in one or more transactions
that might prevent or render more difficult or costly the completion of the takeover transaction by diluting the voting or other
rights of the proposed acquirer or insurgent shareholder group, by putting a substantial voting block in institutional or other
hands that might undertake to support the position of the incumbent board of directors, by effecting an acquisition that might
complicate or preclude the takeover, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, our articles of incorporation
grant our board of directors broad power to establish the rights and preferences of authorized and unissued shares of preferred
stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to
holders of shares of common stock. The issuance also may adversely affect the rights and powers, including voting rights, of those
holders and may have the effect of delaying, deterring or preventing a change in control of our Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Cumulative Voting.</I> Our articles of
incorporation do not provide for cumulative voting in the election of directors and accordingly do not allow holders of less than
a majority of the stock to elect some directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Vacancies. </I>Our bylaws provide that
any vacancy occurring on our board of directors may be filled by the shareholders, by the board of directors or, if the directors
in office constitute less than a quorum, by the affirmative vote of a majority of the remaining directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Special Meeting of Shareholders.</I>
A special meeting of shareholders may only be called by the chairperson of the board of directors, the president or the board of
directors or by holders of at least 20% of all the votes entitled to be cast on any issue proposed to be considered at the special
meeting.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>Description of Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our articles of incorporation permit us
to issue up to 2,000,000 shares of preferred stock in one or more series and with rights and preferences that may be fixed or designated
by our board of directors without any further action by our shareholders. We currently have no shares of preferred stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the limitations prescribed in
our articles of incorporation and under Washington law, our articles of incorporation authorize the board of directors, from time
to time by resolution and without further shareholder action, to provide for the issuance of shares of preferred stock, in one
or more series, and to fix the designation, limitations, voting powers, preferences and relative rights of the shares, including
the right to convert the shares into shares of our common stock, and to fix the qualifications, limitations and restrictions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>Description of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may issue warrants for the purchase of
any of our securities, including the securities we are registering. As explained below, each warrant will entitle its holder to
purchase the securities subject to the warrant at an exercise price set forth in, or to be determined as set forth in, the related
prospectus supplement. Warrants may be issued separately or together with securities. The warrants will be issued pursuant to warrant
agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The particular terms of each issue of warrants
and the warrant agreement relating to the warrants will be described in the applicable prospectus supplement, including, as applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the title of the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the initial offering price;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the aggregate number of warrants and the aggregate number of securities purchasable upon exercise of the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if applicable, the designation and terms of the securities with which the warrants are issued, and the number of warrants issued
with each security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the date on which the right to exercise the warrants will commence and the date on which the right will expire;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if applicable, the minimum or maximum number of the warrants that may be exercised at any one time;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>anti-dilution provisions of the warrants, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>redemption or call provisions, if any, applicable to the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any additional terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of
the warrants; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the exercise price.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of warrants will not be entitled,
solely by virtue of being holders, to vote, to consent, to receive dividends, to receive notice as shareholders with respect to
any meeting of shareholders for the election of directors or any other matter, or to exercise any rights whatsoever as a holder
of the securities purchasable upon exercise of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the case of debt warrants, the prospectus
supplement will contain, where appropriate, the following additional information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the designation, aggregate principal amount, currency and terms of the debt securities that may be purchased upon exercise of the debt warrants; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Symbol">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the designation, terms and amount of debt securities, if any, to be issued together with each of the debt warrants and the date, if any, after which the debt warrants and debt securities will be separately transferable.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>Description of Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may, from time to time, issue units comprised
of one or more of the other securities described in this prospectus in any combination. A prospectus supplement will describe the
specific terms of the units offered under that prospectus supplement, and any special considerations applicable to investing in
those units. You must read the applicable prospectus supplement and any applicable unit agreement for a full understanding of the
specific terms of any units. We will incorporate by reference into the registration statement of which this prospectus is a part
the form of unit agreement, including a form of unit certificate, if any, that describes the terms of the series of units we are
offering before the issuance of the related series of units. While the terms we have summarized below will generally apply to any
future units that we may offer under this prospectus, we will describe the particular terms of any series of units that we may
offer in more detail in the applicable prospectus supplement and incorporated documents. The terms of any units offered under a
prospectus supplement may differ from the terms described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may issue units consisting of common
stock, preferred stock, warrants, subscription rights, debt securities or any combination thereof. Each unit will be issued so
that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the
rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that
the securities included in the unit may not be held or transferred separately, at any time, or at any time before a specified date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will describe in
the applicable prospectus supplement and any incorporated documents the terms of the series of units, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the designation and terms of the units and of the securities comprising the units, including whether
and under what circumstances those securities may be held or transferred separately;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any unit agreement under which the units will be issued; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any provisions for the issuance, payment, settlement, transfer, or exchange of the units or of
the securities comprising the units.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions
described in this section, as well as those described under &ldquo;Description of Debt Securities,&rdquo; &ldquo;Description
of Common Stock,&rdquo; &ldquo;Description of Preferred Stock,&rdquo; &ldquo;Description of Warrants&rdquo;
and &ldquo;Description of Subscription Rights&rdquo; will apply to each unit and, as applicable, to each security included
in each unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue units
in such amounts and in such numerous distinct series as we determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each unit agent will act solely as our agent
under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder of any
unit. A unit agent may act as our agent for more than one series of units. A unit agent will have no duty or responsibility in
case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate any proceedings
at law or otherwise, or to make any demand upon us. Any holder of a unit, without the consent of the related unit agent or the
holder of any other unit, may enforce by appropriate legal action its rights as holder under any security included in the unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We, the unit agent, and any of their agents
may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate for any
purposes and as the person entitled to exercise the rights attaching to the units so requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="a_014"></A>Description
of Subscription Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may issue subscription
rights to purchase common stock, preferred stock, debt securities or other securities. These subscription rights may be issued
independently or together with any other security offered hereby and may or may not be transferable by the shareholder receiving
the subscription rights in such offering. In connection with any offering of subscription rights, we may enter into a standby arrangement
with one or more underwriters or other purchasers pursuant to which the underwriters or other purchasers may be required to purchase
any securities remaining unsubscribed for after such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The applicable
prospectus supplement will describe the specific terms of any offering of subscription rights for which this prospectus is being
delivered, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">the price, if any, for the subscription rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">the exercise price payable for each security upon the exercise of the subscription rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the number of subscription rights issued to each shareholder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">the number and terms of the securities which may be purchased for each subscription right;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">the extent to which the subscription rights are transferable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">any other terms of the subscription rights, including the terms, procedures and limitations
relating to the exchange and exercise of the subscription rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">the date on which the right to exercise the subscription rights shall commence, and the
date on which the subscription rights shall expire;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">the extent to which the subscription rights may include an over-subscription privilege
with respect to unsubscribed securities; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">if applicable, the material terms of any standby underwriting or purchase arrangement
entered into by us in connection with the offering of subscription rights.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The description
in the applicable prospectus supplement of any subscription rights we offer will not necessarily be complete and will be qualified
in its entirety by reference to the applicable subscription rights certificate, which will be filed with the SEC if we offer subscription
rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may offer and
sell the securities in any one or more of the following ways:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>to or through underwriters, brokers or dealers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>directly to one or more other purchasers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>through a block trade in which the broker or dealer engaged to handle the block trade will attempt to sell the securities as
agent, but may position and resell a portion of the block as principal to facilitate the transaction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>through agents on a best-efforts basis;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>in &ldquo;at the market&rdquo; offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices
prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on Nasdaq or
sales made through a market maker other than on an exchange or other similar offerings through sales agents; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>otherwise through any other method permitted by applicable law or a combination of any of the above methods of sale.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In addition, we
may enter into option, share lending or other types of transactions that require us to deliver securities to an underwriter,
broker or dealer, who will then resell or transfer the securities under this prospectus. We may also enter into hedging
transactions with respect to our securities. For example, we may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>enter into transactions involving short sales of our securities by underwriters, brokers or dealers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>sell securities short and deliver the securities to close out short positions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>enter into option or other types of transactions that require the delivery of securities to an underwriter, broker or
                                                                                                               dealer, who will then resell or transfer the securities under this prospectus; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>loan or pledge the securities to an underwriter, broker or dealer, who may sell the loaned securities or, in the event
                                                                                                               of                                                                                                                default,
                                                                                                               sell the pledged securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We may enter
into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in
privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives,
the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short
sale transactions. If so, the third party may use securities pledged by or borrowed from us or others to settle those sales
or to close out any related open borrowings of securities, and may use securities received from us in settlement of those
derivatives to close out any related open borrowings of securities. The third party in such sale transactions will be an
underwriter and, if not identified in this prospectus, will be identified in the applicable prospectus supplement (or a
post-effective amendment). In addition, we may otherwise loan or pledge securities to a financial institution or other third
party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may
transfer its economic short position to investors in our securities or in connection with a concurrent offering of other
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Each time we sell
securities, we will provide a prospectus supplement that will name any underwriter, dealer or agent involved in the offer and sale
of the securities. Any prospectus supplement will also set forth the terms of the offering, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the purchase price of the securities and the proceeds we will receive from the sale of the securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any underwriting discounts and other items constituting underwriters&rsquo; compensation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any public offering or purchase price and any discounts or commissions allowed or re-allowed or paid to dealers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any commissions allowed or paid to agents;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any other offering expenses;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any securities exchanges on which the securities may be listed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the method of distribution of the securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the terms of any agreement, arrangement or understanding entered into with the underwriters, brokers or dealers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>any other information we think is important.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If underwriters
or dealers are used in the sale, the securities will be acquired by the underwriters or dealers for their own account. We may sell
the securities from time to time in one or more transactions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">at a fixed price or prices,
which may be changed;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">at market prices prevailing
at the time of sale;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">at prices related to such
prevailing market prices;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">at varying prices determined
at the time of sale;&nbsp;or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">at negotiated prices.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Such sales may
be effected:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in transactions on any national
securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in transactions in the over-the-counter
market;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in block transactions in
which the broker or dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of the
block as principal to facilitate the transaction, or in crosses, in which the same broker acts as an agent on both sides of the
trade;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">through the writing of options;&nbsp;or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">through other types of transactions.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Any
securities covered by this prospectus that qualify for sale pursuant to Rule 144 under the Securities Act may be sold under
Rule 144 rather than pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The securities
may be offered to the public either through underwriting syndicates represented by one or more managing underwriters or directly
by one or more of such firms. Unless otherwise set forth in the prospectus supplement, the obligations of underwriters or dealers
to purchase the securities offered will be subject to certain conditions precedent and the underwriters or dealers will be obligated
to purchase all the offered securities if any are purchased. Any public offering price and any discount or concession allowed or
re-allowed or paid by underwriters or dealers to other dealers may be changed from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The securities
may be sold directly by us or through agents as designated from time to time. Any agent involved in the offer or sale of the securities
in respect of which this prospectus is delivered will be named, and any commissions payable to such agent will be set forth in,
the prospectus supplement. Unless otherwise indicated in the prospectus supplement, any such agent will be acting on a best efforts
basis for the period of its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Offers to purchase
the securities offered by this prospectus may be solicited, and sales of the securities may be made by us directly to institutional
investors or others, who may be deemed to be underwriters within the meaning of the Securities Act with respect to any resale of
the securities. The terms of any offer made in this manner will be included in the prospectus supplement relating to the offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Some of the underwriters,
dealers or agents used by us in any offering of securities under this prospectus may be customers of, engage in transactions with,
and perform services for us or affiliates of ours in the ordinary course of business. Underwriters, dealers, agents and other persons
may be entitled to indemnification against and contribution toward certain civil liabilities, including liabilities under the Securities
Act, and to be reimbursed for certain expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Subject to any
restrictions relating to debt securities in bearer form, any securities initially sold outside the United States may be resold
in the United States through underwriters, dealers or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Any underwriters
to which offered securities are sold by us for public offering and sale may make a market in such securities, but those underwriters
will not be obligated to do so and may discontinue any market making at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The anticipated
date of delivery of the securities offered by this prospectus will be described in the applicable prospectus supplement relating
to the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Any broker-dealer
participating in the distribution of the securities may be deemed to be an &ldquo;underwriter&rdquo; within the meaning
of the Securities Act with respect to any securities such entity sells pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">To comply with
the securities laws of some states, if applicable, the securities may be sold in these jurisdictions only through registered or
licensed brokers or dealers. In addition, in some states the securities may not be sold unless they have been registered or qualified
for sale or an exemption from registration or qualification requirements is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There can be no assurance that we will sell
all or any of the securities offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_016"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">Mitchell
Silberberg &amp; Knupp LLP, </FONT>Los Angeles, California, will pass upon the validity of the securities offered in this prospectus.
Any underwriters will also be advised about the validity of the securities and other legal matters by their own counsel, which
will be named in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_017"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Gumbiner Savett Inc.,
independent registered public accounting firm, has audited our consolidated financial statements included in our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419013533/tv512925_10k.htm">Annual Report on Form 10-K for the year ended December 31, 2018</A>, as set forth in their report, which is incorporated by reference in
the prospectus and elsewhere in this registration statement. Our consolidated financial statements are incorporated by
reference in reliance on the report of Gumbiner Savett Inc., given on their authority as experts in accounting and
auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_018"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have filed with the SEC a registration
statement on Form S-3 under the Securities Act of 1933, as amended (&ldquo;Securities Act&rdquo;), with respect to the securities
covered by this prospectus. This prospectus, which is a part of the registration statement, does not contain all of the information
set forth in the registration statement or the exhibits and schedules filed therewith. For further information with respect to
us and the securities covered by this prospectus, please see the registration statement and the exhibits filed with the registration
statement. The SEC maintains an internet website that contains reports, proxy and information statements and other information
regarding registrants that file electronically with the SEC. The address of the website is http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the information and periodic
reporting requirements of the Exchange Act and, in accordance therewith, we file periodic reports, proxy statements and other information
with the SEC. Such periodic reports, proxy statements and other information are available for inspection and copying at the website
of the SEC referred to above. We maintain a website at http://www.clearsign.com. You may access our Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed pursuant to Sections 13(a) or
15(d) of the Exchange Act with the SEC free of charge at our website as soon as reasonably practicable after such material is electronically
filed with, or furnished to, the SEC. Our website and the information contained on that site, or connected to that site, are not
incorporated into and are not a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_019"></A>INFORMATION INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC and applicable law permits us to
&ldquo;incorporate by reference&rdquo; into this prospectus information that we have or may in the future file with or furnish
to the SEC. This means that we can disclose important information by referring you to those documents. You should read carefully
the information incorporated herein by reference because it is an important part of this prospectus. We hereby incorporate by reference
the following documents into this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419013533/tv512925_10k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K for the fiscal year ended December 31, 2018, as filed with the SEC on March 12, 2019</A>;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419026025/tv520466_10q.htm" STYLE="-sec-extract: exhibit">Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the SEC on May 14, 2019</A>;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">all information in our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419018098/tv517849-def14a.htm" STYLE="-sec-extract: exhibit">definitive proxy statement filed with the SEC on April 4, 2019</A> to the extent incorporated by reference in our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419013533/tv512925_10k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K for the year ended December 31, 2018</A>; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">with the exception of the portions of the following filings
that are furnished rather than filed, our <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419000918/tv510139_8-k.htm" STYLE="-sec-extract: exhibit">Current Reports on Form 8-K filed with the SEC on January 7, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419001360/tv510871_8k.htm" STYLE="-sec-extract: exhibit">January 10, 2019</A>,
<A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419003769/tv511973_8k.htm" STYLE="-sec-extract: exhibit">January 30, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419006685/tv513264_8k.htm" STYLE="-sec-extract: exhibit">February 12, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419014892/tv516656_8k.htm" STYLE="-sec-extract: exhibit">March 19, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419017766/tv517915_8k.htm" STYLE="-sec-extract: exhibit">April 2, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419020286/tv519176_8k.htm" STYLE="-sec-extract: exhibit">April 18, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419025466/tv521349_8k.htm" STYLE="-sec-extract: exhibit">May 13, 2019</A>, which was amended by <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419029787/tv523111_8ka.htm" STYLE="-sec-extract: exhibit">Amendment No. 1 filed with the SEC on June 5, 2019</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/1434524/000114420419030688/tv523444_8k.htm" STYLE="-sec-extract: exhibit">June 12, 2019</A>.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Additionally, all documents filed by us with the SEC under
Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than any portions of filings that are furnished rather than filed
pursuant to Items 2.02 and 7.01 of a Current Report on Form 8-K), after the date of this prospectus and before the termination
or completion of this offering (including all such documents filed with the SEC after the date of the initial registration statement
and prior to the effectiveness of the registration statement) shall be deemed to be incorporated by reference into this prospectus
from the respective dates of filing of such documents. Any information that we subsequently file with the SEC that is incorporated
by reference as described above will automatically update and supersede any previous information that is part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon written or oral request, we will provide
to each person, including any beneficial owner, to whom a prospectus is delivered, without charge, a copy of any or all of the
documents incorporated by reference, other than exhibits to those documents unless the exhibits are specifically incorporated
by reference in the documents. Please send requests to ClearSign Combustion Corporation, 12870 Interurban Avenue South, Seattle,
Washington 98168, Attn: Brian Fike, Telephone: (206) 673-4848.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 49.5pt; width: 222.75pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ClearSign Technologies
Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">Prospectus Supplement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 14pt"><B>National
Securities Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">August &nbsp;&nbsp;, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 45; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" 2D# 2(  A$! Q$!_\0
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M1J:9W>1ZTN:^7]+^)GBRVL;NSBO[J[O+MD2*60F1H@,YV#^\<C\JIW^E>/(
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M_P ?>I_]<X_YM5#XF?\ (S1_]>R_S:K_ ,*_^/O4_P#KG'_-JH?$S_D9H_\
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M22./:IO@%93K#K5^R8@D:*%&_O,NXG'TW"JG[U/F:LQ1TE9'GO@G_DJ.E?\
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EXTFQ#H 5;[.F0>>G%%%:+8E_$>C#[U.HHJ"@HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2028978-1_424b2img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2028978-1_424b2img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !: :P# 2(  A$! Q$!_\0
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M_F4UYFR/<D<\'J:]J\(^.?!/CO1K;Q)X(\8>'/&V@WBXMO$'A36]*\1:5>#
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M]_L4? ;Q!<>#OC/^UG^SW\,_&%J&74/"?BSXL^"])\4:=E02=3\/RZX-<TH
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M\GB/_!47_DQ+X^_]@KP/_P"K.\!U^A&=@R3D]AQ^N!C\.O?C%?G[_P %1/\
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M)8>UGAW4E'E225K/GFK*UG%-*VAIP_F_ME5PF*^.CR^Q^7M.>_\ X#'\2_\
MMG_MK_#_ /9!\%6FIZY:MXC\;^)3?1^$/!=M= '4&CCQ_:NMS%C)H_A^,X$D
MY&S<QB1C(DNS^3OX^?M5_';]HWQ--K7Q+\<:GJ5LMTJZ-X3TMVT_P1H(  !T
M71G+.[8ZN[%V/+%B2:ZG]MW]H/5?VE/VD/B!XXGG'_"/Z7K.J>"_ EI_SX>!
M-#_M_0B?^YL/_%4?37\5^D__  2]_P""?'A;XE>&H/VC/C=X=LO$7AZXO=2M
M/AAX-UIX]0TC6(] >/0YO&FOZ(SJ5D&L:)-X>C\+D-&HBW2X7:DGU.3Y7D/
M>1QS3-,''%8ROA\-B<,KK]W.M&I4G3A?>ZE"[6KY)2D^6UN;$X_,LVQE7+**
MM1I-*?I.Z3>G]Q_\/<_'CP5\!/CI\1M"7Q%\.O@C\6/'OAAB0OB#PIX%\8^(
M]-8@%B%ULD9(&20.0 3C@T>"?B1\8?V?/'EOKG@[7/%OPW\;Z#>#[9:?\@W4
M_P#L"ZYH9S_PD(X_Y%;Q8*_O3MK*QLHHX+2U@@MX?NP6]NBJ.-HVA H4CKD
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MH86LZJ2U]^$G"_W2UV_%+_(?_;>U[6X/VT?VP/(UO6_L_P#PTY\>?^7P\_\
M%S_'OH1VST'3GTK_ $=O^"$32W__  2:_8ZO+B:>XG?PCX[)-U]YF_X7'X^
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M]\%/B5XT\-ZACDC1=:T#PXP8X&<*1CJ?2M'X!?M*_M3?L#_&IO&'P>\5>/\
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M0-'T;0-+LA9Z1H6E:5IFG:;9:=$G_(*TK28DC@A1D7+1+&D09BV#G8/XW/\
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MBL%A%@,+@\&E94<!@[+LG3V_#\;]3\XQ..]MB<14_FQ%7\),*[?X<_$;Q?\
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MG'&<_P JM9+\92/\O#Q?#KUIXF\0V/BHW%SXOM?$OB:R\2W5WW\4C66_MS
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ML&_]G?? ;_U9V@U_KFIT/U_H*_5_'C_DJ,!_V*J/_N,_.?"/_D79K_V%T_\
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ML5?&CZP/+S)H,K[%>/>,<,H!)5OY-?C5^SO\:/V<?%EQX7^*7@_4O#E_I?\
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MC:"TV2<FUKI?K8_Q[/VWCYW[:/[8,\'7_AJ?X\8Z\'_A9_CT^_H?\FO](_\
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M-KI^GVZ[+6SM1\MF""" #P<Y.0.F<=.*TX._X_TJQ10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !59MK(2">G3Z'UP/Y=CZBK-01]!]%_FM*4>:G-7M9)I^:=
M_P!#.4Y1G32>DKIK[K?<?SY_\%\_V"_VGOVW/V88K+]G;XA^+KC6_AS?C5_$
MG[.>GZC8Z?X'^/.G'5=&F7S7DB4'Q]X0BA3Q%X*T7Q;<-X)ENUDA=;>Z">*1
M_G*7L/Q,^!OQ+'VR+QO\'/BS\,/&&+7_ )#/@GQSX#\4Z#G'7;XFT#Q#X4.#
MS]WOG@M_LVZC_JC]/ZU^#'_!P%\$?@QKO_!/GX^_%77/A%\,-9^*'AGP_I0\
M-_$C5? /A34?'OA\?VK;G&B>,+S29O$.E#))Q8:C;C))[FOUWPYX^Q>#=/AS
M$82GBL%B:]&E"\HP]DZCJ\[:4%SJ;C>3;<[J*YI)*WY5QUPO2JO^UJ&)GAZ]
M)59SM%R=1OV5M>96Y4FEI9J3/XF-+_X+F?\ !5W1M!@\-V/[:WCR;1^;4W=W
MX9^&GB35,^O_  FVO>&3XIS_ +7_  E_OFO@[XV_M&?'_P#:B\8V_B_]H#XO
M?$7XT^+;:VEMM)U/QIXBU?Q"MAITTIEETC0=#4;= T&5W>63PUX53+2,\C!F
M.:^>97?:3O;/VSKN.>A[YS7]Q?\ P:I?!7X-^+/@Y\5_BEXJ^$OPR\2_$WPM
MXU\+CPQ\1O$'@/PMK/COPX/[#8XT+Q?J.E7/B#2!GG_B7ZA;U^VY]B>'^"<!
M#.<%PYA*N-Q%*<HU.:%)T90]DKPY::TE+$)M:? M'<_-\NPV.SN;P.*S*LZ2
MG!)M<SM=]+I7M&VS77T\>_X(/_\ !##XCV7Q'\)?MK?MF> M:\ :9X O],\8
M? WX.^*K1=.\4ZQXI:$R:%\3?'.@E7\1>'#X15D?P7X8N3!XKA\6%KJXECAC
M(;^Z*))1%@D GG']._7IVK%M.$4#@'.0. >.X%=)7\J\1\2YEQ1F57'9A43C
M&4XX>@KN-"+E[T8MVNI<L&W:[<==+)?T1D614<ARZAA:-6=;GA&<IS26MKJR
73=OB:W[=@HHHKP#V0HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2028978-1_424b2img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2028978-1_424b2img002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 10$H P$1  (1 0,1 ?_$ ,@   (" @(# 0
M       *" D%!P0+ 0,& @$!  (# 0$! 0            4& P0' @$("1
M  8! P($ P,%"@H+     0(#! 4&!P 1"!()(1,4%3%!"E$B%F$R(Q<Y<5(S
MLR1TMK<8>)%B4S0EM79W.!E#1%2T-776-X=8>1$  0,"! ,#" 8(!00#
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MT&16T&9SJH#]ROBR9FPD>1^.(\P&;B0<K0C%$=E&YA!-*\-VY $"J(&V3D@
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M='.AIYUYZF\PLGK&O2-$0 @/B [A^32M<0BX3N1CV )"^?LF0.%/)0%VZ0;
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M'#XE.HT66(4P?8([Z^O8_3_B M[Q1?&O8\T:03V&JRNO ((J,0O2-?47C</
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MA790K57U#8LE"5^/C'Q6Z_03SD0=-C=!]@ZB[#MXZH^L0Z27M]TDGSDJ:TL
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:K'!^5_\ UNGZ=_%6O:A5)(T1&B(T1&B+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2028978-1_424b2img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2028978-1_424b2img003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ V@$: P$1  (1 0,1 ?_$ ,0   $#!0$! 0
M       &!P@! @,%"00*"P$!  $% 0$!              $" P4&!P@$"1
M  8! P,"! ,%!04% @\  0(#! 4&!P 1$B$3"#$402(5"5$R%F%Q@9%"H=%2
M(Q?PL6(D&,'A\8(SPB5#4V.#DS24U"969I;65PH1  (! P,# @0% @0$ PD
M   ! A$#!"$%!C%!$E$'87$B$X&1H3(4L17!T4((\%)B(^'Q)'*"DJ(S0S0E
M%O_:  P# 0 "$0,1 #\ ^_C0!H T : - &@#0!H T W.5,KT3"U*E<A9(FPK
M]4AU6#=T^*PDY9VL]E7K>-BHZ,AX1E)3,Q*24@Z310;-6ZRRJA@ I1T!X(G,
MF.+!%8TG8:S,Y")S$)0QJ]03=BE:1-!/;+Q:@=L0[10L)&KK&(X!$Q!2,0P
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MI5,WR"3AS!P%\Q6Z,\J48;ON*=)N,>PM@9N#,TF!C*.P3**NY5P ?SQI\?\
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MB/$NX^H[!N/[] '$OKQ+N'IT#I\= 6*))*%V42(J AQ$IR%/N ]! 0, @("
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MQG(&.L5!$%P1**BFP#R*9#>2Q.5+J\G8FQ2F%Q+O52U6%;&Z<2^YFT4GKOU
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M>$8JTW22MU2TZ-T=/ZFJ\EWGD=K%N7=OBLG)NWZRK*FLJ_71):]J=->A''S
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M-Q5\8Y2W_)E<^^W)RI5)-UH_E7KU]3Z3T3\R$'D!@,F4P"42B!@$ V, EZ"
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MO2\E$2\K!1,G*P!G:L'(OXYF[>PRCTJ1':L4Z<HJ+QRKDB! .9$Q#& @ (]
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M0'D<4VHNTP2=5:NN$@-R!-:%C5" 8/Z@*9L(;Z \/^G5 _\ R34__P!O1/\
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MUU8U]_4!S:L2QQ3 4JMY=/SJ;")RC$T^QO$R%#\HE7$_$PCZ /3KJ0.L @
M&X=.GKH W#?;<-_WZ KH"@@ [;_ 0'^(== -QBCB-)9&#U+,W$O0?_UE/_\
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M(K(J$615235262.51-5-0@'(HFH41*<BA1 0$.@@.LV90RZ IL&^_P = 5T
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M3D1T*H"8!W$.@^F@''=Q[*01,W?M6[YN8!*9!X@BY1, ^H&26(<A@'X[AUT
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M*-MA+MD^V8XMF-ZS$Y!B9^"DX2(JU,:%5K+Z9F4VX14 V4$G8;G15,)^)A(
M:U/W8]GN,>[FQVMDY2KES$LWU>7@XJ3DG7Q?E%KQ_"IP[F7 =EYWBQP>0?<N
M8D9544U3Y:IZ&GQIXQ>+6+G+3*N/LTR]DSCCV2@K%5C9BN\K1&D8E"QBK:TT
MV2ATH>M(.V5CCWSTCQ9Q'/'";GL[[F0(&J/;OV4]O/;.<\OBNWV\;,O:SDN[
MI0HXI[;<0X567'<6./<E^Z2ZR?JSJ96<@R4U@:%R=9(MM7)27QFTN,C"M'HR
M+*-=R,"23*S:/C)IG=M@47*":ABE,8H@)@*.X!UM*FBZ&^:O5]1?46+-"4ZJ
MQ!BF*=A7HELL!QY&*NFQ2[X"8!$!V6$P>HZ 5N@#0#;9<543Q]/I(E!1>1"+
MAD4O4ZJDW,QT2"2!=PYN#@\'MA\3[;]- .,F&Q0#KL41*7?UXE$0#^P/Y: U
M4["1]@C'$9))**MEQ24_R53H+HN&RI'#5TV72V51=-7"93IF >ABAOTT TZ5
M=R[4E9 M=ML3>(ARLJ^;,LB$>-YZ-651ZL6UB@$2-W4:+LNY"K,@41*(EYF#
M;4MP4/)]1XR>JI03Q\Z66.<1\3.87R*A87[5S(%BH56I3A#1[%)$'CI)V2Q-
M0)Q=J"1,BQ4S*%V$!Y?+JRKD?'SE)*%>_4EUC#[CC-Q^"%"?+<VX9A(06(LI
M337ER'NQD'7W(HE21644283\ZQ?*F ICE*04RF.HGQ#H8IAN)U5>S*5Y=9*E
M>GK3X_$\V'\A56XRM_4B9!1)\^M8N_H4PR=P=B:I-*U6F;L'L#*(MI-M[1V0
M4SF,GVQ.'RF$H@(R2/QN&PB @.V_Q_#0$99T%<B>0T'5EW+Q&M8:KD=D63CR
M)IIM)F\VEU(1=..X6.)EU$:W$1S]P"9"@07#A,1-NGMI"5R$W.$FDXN+79U[
M_,BDO)-2:7II1DF0( ?M_> ?W!JBW#[<?&K:^)-6W5D=[5D)7%&-<UY,3J]C
MN9:?(WJT%J]1CS2MEGOH$>Q(:,B6!#%.L[<K,S^@&$J8"8"FVV'Y\_+_ (6%
M=RO"4Y0MRDDN[2T3^;/GR,A8UN5V4)2A&W*7T^JZ+\2'/V]O/!_YVP>5H6WT
MV+@)"G#%]N3JI9=Q4;/4;<VD6B#A%29YR$;)LY*/=M#(.B)*.D4 =IIE25 I
M=,]O>99'+,6[<SK#Q]QL7&G&C47%M^+^IMUTUU-:X=RF7(\>[.]9E9S;-QJ4
M6FDTV_%JNO9UU/G/\\O"+S;NV>\MY.JN'7,M4&=DF9):ZP",(I7(V)I\0K %
MGI4)B2:('<I)P?NY)%0YW"KE3N>W,7LFUS#D7"N1;URK(R;KE##;37AIW=>M
M3GV\<0W_ ''D%[);:Q)-?M^;KU/I5^V'0<80/@SBS%E;M5=R1'5MA,1=X19+
M)/(V%NKR=D):RU8(\QU%HA."E'@D;I'XF A2+)_*<HZ[IQ_#6W;3:P?*4I6U
MU?7]#KNT8T<+;K>(G)S@M:]27\:_D\:S,#595P\FJ;-NEXV M4L^%U)P3TC0
MJ\=6;$[< F=X225(HG'.Q,<YA*5!7=0R9C9DR(G)S) 9+D#T'$DK%SI%7$A#
M9"N,8X<NF= 9+0I'R1FCE! 8J5GY-!X1)N@5R!FYUBKG 2DXB _$%#M("'B8
M9D*@M(B+8138RPIBL9NP:I-43+&3(0AE3$2 3"   F$1VT!M]P_'0!H T :
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M22.19! @;G*8L0Y'X; @?UVT _7+_A-Z_P##Z?C^;\N@+M &@#0!H T : -
M6B0!]!$HCZB7H/\ =H#1R56K<R0R<O 0LH0Y1*<LC%L7H'*;U 1<MU!Z[_[#
MH##7*?6:BBY:UB$C8)H\=G?N6L6U2:(*NU$DD3+G32*4O+M(E* !L4 #H&@-
M7<*P>8(WE8MR,7:80JRE?ERIG4(FJL4G>C9)$@@+^%DQ3*1PB;T#8Y!*<H#H
M##3;>G:T7L>^C74-880Z#.RP$DD)%63I5,YDG+$PB=.2@Y(R1SLW11$JR91W
MXG*8H +'Z<R%=-R9JV,ND!@26%NCW4@-T$$U>'<( AZ@ ]=] >W0!H#$HD"@
M& 1Z'+Q$/A^_^W1O2BZATE'Q?0;Z9Q%C&Q2<=,V#']*G):*G6UHCY.7JD!(R
M+:RLV"L4TL*;YU'J.0FFL6N=NFYY"JFD;B4P!JT[4)+ZDG*O6BJ7+=^_:TMS
MFHM=$VA>;$1'CR 1  ,7F/4H!T*4OH.P;=-5RE*JC"+;IVZ%AR<KGC%KS>NH
MS&9W*D! -<FLR&,]QFZ&RO2)JK)*R%0_RR7.(3(FH1)PHYAR=Y BH&(+ENG\
M=AU*C=>E$I^E2]&U<>E8N7P'D;.R.6J#E$0%)P@BX1$P"41263*HF)RCN8HB
M0P;A\-15M^"_>4/5^$/WD6ZC:6$%?\FV?(19./L\U:UJG3&ZD++OC$Q]7"))
MP[2'5;1AT3&G955V^630.<53G3$^YB!M3<NVK,:W[EN#>B3?5]BW?F\:TKEQ
MQ3<TJ5]1]ZUD&%M,C+1+)K/,9"%;QKM\VG8"4@CE;2QGA6*R'U)N@5R58S%4
M/D$1+QW$/35SQG&*=QQ<W_RNM"XZ*3BNR7ZC?IWA"FADM%1LK(O8NY2;R+A6
MJZ*4C-(O*Y6K1)^Q(K_3$)S1U' B!A(BF8^VVP: Q_ZP23M)J,>UQTBI*/C1
M44,KER##W$H4J1_IP-HV+>JN'PD6*(MT#G7+S+N7KMH#&FWRW#7,+=)P]8L;
M5_7RUQQ!5&0>,'3-RE)GD6,JNZM"[:/<(IBX406X[+ 4Q3$(( 8N@%O^H\A'
M-Q2QPFGMOR,\O$0B4=@ >*?M(^0.8P;]>0$  Z[CZ: 8K,-<S7DB)F*V+-I3
MZLG7EYWNUV88STG-3\-,P4U$5]RX?1D8]AU5"13@ 79%.F;O%YF'82"!*V'E
M&<S%Q\HP6(X9R+)N^;*IF Q#I.4B+$ZA_4!3]0]0'0$ /N:$K#GQQ(SM]49W
M"&=9%J"1HE],3L&@5T7ZBJU>^_KSQA( HW43^4G< AN7S!Z:XI_N Y5#AWMO
ME;U+;[FY3A)*-F"DW7QD_)^.M$E2OQ->Y-[E[][3[7+EW'(3GN=M^*44WHTY
M:TUI6*Z'##&<!@YCDK'3MCA*OMGZ%\J"C%PGD/)BYVKK]01P(+IH.+.JW<&;
MJ"!P*H4Q#"7Y@$-]?G_[9_[CGR'G6S8$>(W<;$NWE&Y>\;U8R;[5TIW=?0Y7
MM7^_#WDYGE6>.;QCY3Q<ZXHW'_W*QAT;5=*:]]#M(Z\C\;M<B*04MX89,&U2
M+1^5O8(S$<3,LY!,LLK$RK%W80CVR+4'#5NU53[ZH(N$UBE,9,"".OUGMOR3
ME)>%?'QCW:IU:^'0[KY?=4;D6_!1U3TE5^J-=%YB\=4G[R.-X.7^(>T%L^7
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M>GZ&1>LW-]67[!^W^8_WZD!L'[?YC_?H V#]O\Q_OT <0WWVZAZ".XC_ &Z
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0%= &@#0!H T : - &@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2028978-1_424b2img004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2028978-1_424b2img004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ TP$8 P$1  (1 0,1 ?_$ ,    $#!0$! 0
M       '" D#! 4&"@(!"P$!  $$ P$!              @!!@<) @,%! H0
M   & 0,# P,!!@,' @0'  $" P0%!@< $0@A$A,Q% E!(A4646%Q,B,7@:$S
MD;%"0R0T"F(V4G)3&/#!8Z-$-2<1  $"!0,"!0,!!@0$! 4%  $" P 1! 4&
M(1(',4%182(3"'$R%(&10E(C%0FAL<$S\-'A%O%B<H*24R1$%Z)#<S0E_]H
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M+%(X*D!"%#^J!1'T!02G/W!]I1W  $-@TA'LQ40V54%3L$P=>\P"8Q$3=YQ
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MD(Q]IRWR,J4/.34MQNA91I"P4I*NG=1SC7' @@Q9+.UU"-+75ZF8023;B/\
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M#]P@;;800A4TF?*JBN%0+)8JSK!"'<W!^UD<-W\A2@ F37>QB=PHLVKL&Q3
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MER@4?VZY[1TGK#3OTC=J3&(UFFTV 3*F@E$5*MPZ"?A$!11BH1@Q31*)3B(
M4$/KZ:IL(&Y4@F *%?:9Q?6&)),04C#^[=1QIB,DXXDLS<&3?,1D&JS8'S50
MFYD7345^Y,^P=IR@.^N,(3;#^+G.*8R3CU<@V[(QI1R@_P#>VZ3"1>,A:M?:
M@W:D1*;P)+%)WJB  4Q@+L4! 1,A"NG,!R=H=Q# 3M$ $WWF((G(8Q3)B)1
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MP(V]9;3.76'N%P/(6&6KDEE[+ERR\SJ,ZE8:_4)J!I5:I9)ENB8D++V.!K$
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MC+'9%(JZ8_9W 0#D$#&$0'?2$*'!Q3:MP4- MEWSEK#M6K!!S)KN'DBY18M
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MKW)S.@$MNA$YQ:/SH2W6_(*MO33:Z5FL:"TTI4-K2)[4K^U(,U GT]HY]OD
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MU,8Y1-L6%MNP.@L/-E=R%9/R$UM:\''*<KFP@I3MDVC]PK5-2R/N),;BN/\
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M&[>-,C?(%ZPH647"S($TFSEQ9T7,/)*K([J&7\YE0#N*84(=K]IRF#O(4!V
M0W;AMT V^W_S@'7]XZ0A.<:1>3XJ$?M<JV*JV6<5FWCB+?U"/7@V+6"6!))K
M%.VSLZRCEXQ.D;_J"B7RE,'VE$-(0C',1YAIWARR4_+:T<_=6"/5?X]JK=9H
M_O<UD*OE;2--=XX@W#=^[>VR-M M1;K)MEDT3' %@\1C@/(*D-.L!-*BM/W;
M9"(__DE^.I/E/PZB)1GBZBRG+['6.ZU^G+%' A2XQG,+&@9#*+-%!B6.@U&#
M\C=ZJFFL@<"JE $@ 1 H6!GN,L7ZS+2WZ;FA)+:M0D=-TY3\--/U$2C^(O-M
M3P[RA1/WQP_]H5:_;JTMR*U'HP4[D'1*R2J1&G8]N7CXTODIMWQJ6_*[]QC"
MS92Q]F&OC _I^,D"UR"B<RT-)=]691[,NF+I@=NYA5G;1^F@)GOMP2,1(PEV
MUB/CG**O'K75IK6WW66O2VE*1_N;M3J0-LO#7RC9Y\T_CY0_(O*<5=Q.LM]'
MD]<V ?>J$B=*EOWIJ0VW[@E(F>TB<Q$E? [XHN5_)7)>2>:?,.9BL72N9I1Q
MDVI1ZU+@K](OW-[EU[":54BIZS$E*,-69)L6\1[A,ZAFAOO3()=M<<FX6/,]
M*I_)GZJB9>3O26%!+B@ ?Y:R4J&Q0/J UT$1-Y.^45'P=@MKX/XTJJ6HIK(]
M4-7%]"72RXM1 5[3@1-8"A)14E(GXSA8^:OQQ<K,IP1<A8,RW'SE\X36S)58
MK-,C,7PD?><FED6M/L]:=-5V:B\!)V9=G8EB^1X@0J212@GW")M?3<N!,&L&
M$-VC':1+)IFC[Q6KU/JTD?0A))GXK$HQK\9/DG:,7O\ =,3Y"J7*6R9+4LE=
M2@+<12-DDAQR0*D(49!6Q*M-2.L/PF8SY1..'"-DE@9KB#(5BJ6-L6(TS&LY
MC"5',];=&CXDM^B)%K V*'Q[;9^+?.G*B8@@B*A43&4!PLH81S*&+A9,3H6L
M9I]]P8MR0EEQ0&]7IF$D$]$S.I[1@#&\<XWR?FY^U9A>:BBXXJ[N^XBN;3-:
M6$J7M7ZI2][0)W= O4"4<^?R$\'N3.$L>84^0*RY'RE;.4^2)5]EC.CFR5N"
MA%<+.8=BR<A$LA.Y<-V<=#,))6/0C@[DTFQ-D$@V,;4?>5;90*H6F,S?4]47
MDFE53*"B&_=!$AMT&O0S&OEK&RGXZ\I\5UMROO"=FH+;2\?4%SIW6*QM0%3<
M&TKVK0\I4BD/)$R4%1!.G::X_'-\KM7J.7<;0F6L67*U7"T.XK%D79JK(,7"
M:TY:I*"KS.SR,:^4:]KQ^JZ<*/A3[NTA@!,##Z8#^.>!4?&'*AN]%6U+V-7'
MW&VZ51)#2R9 [2=H2.TB3%T_*GX>7;(L)N668E66^D;M='_4'F%>X'DTH"EA
M.X-&:PE(ZJ (GK'72Q+GIME"7&7>X^5P\L>3+#M&J<NWO[$2H1Q8A9P[/Y8E
M\FJZ3=%<%^PP$6()1$2ZV5$J!D$DCRC2:&7G I32"I($YCH?I$0W/7YL:-PX
MS<3CV7"-PO<[#F04R$_>S,17636N6.MB[@).CN!-(C/NG+IR4JWNDVQ"$343
MW$PEUC#*N6*3&+H+544Z]Q.JDI!3+]2)_LB<GQ\^#&8<_P" G/:2Z4-'2B:6
MD.-/.N(6D_S Y)HI2&TZG:5'PG'%W6YN*Y/<H<506;()*P5R<SYA^E6VH5Z2
M=5%E8JA(S\+4H:(":B7#>5BY>$BGB*SM41!11T0#"/:< +C>P78U>6)N+S:E
M,U2I)&DTS/?R\/'I$ZN3>.W<;^,ERQ2P7-U53AVQ\5C"4/IK%@ ^ADJ_EI!,
MU'[D?PF/TS>/G%W ?%FG#1./>)Z3B:J.782,C&4^)(P/-2 (E0"4GY%0%96>
ME!2( "N\654]>O4=22:I:>F)]E,E?\?\=XT@WO(K]EM:;ODE6[4UCBBHSZ34
M9])"0/@ /I#@"E[2@7]FN\F9F8\PF>O2/6J12#2$,?\ D#EKU2N-EJR]BK'\
MQDK*6#)JM9>H]3KXM@EI1>I2Z*EL9$]PNCY&,GC]S+M7220*KJH+&!))17L*
M/R5%2ZTV5( DF/0M5%37&N;I:Y8:86K;N)D/+_&.1GY0?D&X;\_L85#,F$\Q
MY,H68&",?C^>XU62&E8J-R#7%I1Q8"6R:D(Q=W4Y(]*7(8C<3+'.F=3L'M/]
MFL+<J.T55;??IZD)J2![B"H"6O0_33I&U/\ M^VC(\0Y#7AU9CJ:NRW,/U%)
M? @J-(BG1_-13*E*50DE*@% ]>NL1"8 H3O(.8J;!M;#3H5]&R\?:HT+:J!8
MJ7DZ<]8V*.JJY3J%15<6:09)LR .^WE,8Q3 ':,2+]DS>'T@O\EN,L@B;:-Z
MDN$F2P/!.BB>DIB-JOR-2E? ]UQYBF=J4W1MM1=2W-:&%H2K:2-04CTR[2CO
M+K7R!RA,<8CN?X*%N"MWHZEDN*#)X:!FJQ.)34A#RE.?1I$7C=C.5QY'*MW(
M*=@G5()@(0H@&O9Y"^:1X;;QFCR&BIKI676C2ZXZT^"I*2924D#TRTVSZSC\
MZN+\$OYH]>E4#BJ;\-Y3;*704[D($Q,'4$SUET,4LA?(=9O:Q:N+<:(N'*Z$
MB29"W3B*)$ .Q*M$&C%8M<H+"+WN36%0G0BA% W[!(;RV?[DW$%6FKIW*&NH
MW2TN2E,E1*]NT$$*Z3';PG'UTWQ8S1+-+5AVF4P2"?YLB-3,2(,XY,/E4N]Q
M>WG%M?<-I&,0B(&5M#B>3,Z8-9BTSCM-*5_%.P,"P&CB--Q %!. +!OZ (Q:
M^-M!0W6WY#EBGFJBHN%Q+Y02"0T22 09ZDKZ>76-[?PIP7&TX]4,7I+55=+>
MRTH-*D06DI5NVSZD*[?2&(8_HW)CE,Z<T.I3E@OE=QO')W-]6[!<Q!BT>S K
M04*Z8#/NC)*2() Z A /T()AUG2]9!QMQ=3?UZ[IIK5>;DZEE#@0 7 W)QP*
M(E)(2I)GYQESD&\\8\4\K6:\U%N3;WW*5]U:J=L+)0Z@):WA,MI"@HD=HP-W
MX^YEQ<LS"^8ZME72D9%&!C)%ZT07BGLN_$4V<>VDF2Z[5PX>& 0(4#@)MA'T
M =>CC6;X3DSU1_0;G25"MBER;7,AO8=Q(EH J49#9YAQ7)K+^59ZQMVJHF_=
M6@D)4&]X"B03_">GCI$DF3>(7/&_\2L,5N-X[76]1V.;-<"/K'CU*NV6,_3[
M1@V;P;5VE6I9R_,_BO<.BNO,W*H38!-W;[ZZ, XCNEXR>LY2L;!<L]Q8:ID*
M<D!O:42Y-))*>@VG6?:(;XE\B/C'B7/.15]YO-*TQ<4H+(JD$%+L@%) ,P-R
MOL(ZR/24-.X#<HJSP\YH8ARYEN+O%GI>.%;XN_IM:>-E9!.=4JLI6XI4L9,2
M#.- L/(R1E%"@8IRBF';UW <V\<W*V8M>W,BNR4(:9<4W-I *@H@I.@D=I!T
M/>+G^9_!;_.''EIX]XN%N;R:Z.?F)4I8:2MEL!X;5[9$J2DS&FD==>*OF#^,
M+EG>*1C&3QG,#>,A6&.K-?C\CX+K\PT<3,JX(U:(K3J!IILT1\R@"=8QB%(7
M<1$  =26M?+N'W-P,-/K0M1EN=1[;8TG-2B9 >?TC3!R7_;\^0?%&+5F997;
M[>JP4K1<<4BK0XYL! )#80"3J-)Q'#\TTO1ZW0J#D;B<M=^/EIQKD&=J%^+C
M.W3>/86QPTN"K.'=D:52P,X^1<L9V+\B)C(>5))4P"/;J,.9?*7$LORY[CW"
M*BK-_I KWEEDI8DGKL=W$*GTE( _MB1WP!X&QRZ9\[;N7[32W?&;E:5NTS;G
MK#:@DF:QIL($I#J3$+F)LJ<^.4TV.+8;E9FB;;58T=D 8ZZ97G9&(9N*P\;H
M-91L$N68(:38*2)A1W#8=Q$1Z:L7E3FLVC&:E&:.*N&,5"$-%E3?N)WD:31,
M3 4-3/S.D3[SSXM_$SC7'O\ O<8ZY3W&K6MNF_&<* A0!D5),]H! ^O2)GK&
MED'$U0D[W0<Z9JB)^K5A><2/)RD'(M'4@0S55%![YJBHX<1[YV78Z(K$*8OU
M =M0 XIYH5;,\2+#:Z.WW2KN/XX>IEN-*]LD_<&5)1H/+;Y1KJS?$:"YVI]N
ML*UTPU:"@#_U3$\_$_E?-99L+[&F36[69L#YNNYCG;*,C6L.$:QB$W$DUDD1
M.!UE%U5![0!$2]OVCTUL=^)ORPNW+EX7A66I6;]M<6A2$CVRVV2)E>X2,ATE
M,Q$3F3AJCPNA&068SM*7$MJ"CZ_<5*4@?W?.'[1$-7X%FHQKT-#P+18YW"C.
M%C8J+:K.SH%3,X,W9)-D14.F4 $VVX@ :V"2 T'2(Z$%)*3U$97M(([B!0$1
M$1_TC?\ //OT!7M_X?V:X.+#<IS,_#6 25&0AGG)ZSQN+L@\8\R2S"QN8.N9
M(L]"L3NIUB6M<L1IE7'\E U]@:O5YH_F7[>6O#"+1**:1R)K^,3[!VCH7$!6
MU1D?."TJ;Z@D^6L;?_\ ==CL-]J9R(64W ?;I\:,U><Y?YM@ U**7?H(=1Z:
MYC:H320?I''UA"G"A80GO+KY)\3%%'E#'O1,6(P;RGE-]^PPX*L5?1 -M^X7
M%J>5U(H"([[F,&WJ(:325; 0=.L]/I/QCF$DI2K0;A/S'D? ^4)9CZ_L\]<I
M_P!75JG6VG!QZH-MQSD\]^B4Z_9QMV1WE5L59H#:*,^DVRT?$0L0:;4E69U$
ME!<MDDES@=4H=3C[;))?.QL">Y6B?I/QCKWHF02-P[=S]/&*WR*\P6_!KC-9
M\\_V^D,D.6<Q$52-K*#P\?%*R5E46;MW-FE4T'*D57B))&357(BJ;R'(0"B)
MNELY7DS5BL3E>VTNI:44@;$[@9GL?\XS;\>^'JSG7D^BX_IK@Q9_>2MXU3YD
MEOV4[_2/WE'I+MUABV<.*.">;O#3A!6HJ@/.,N/,G9LQ_D]U5*; Q<).5Z5L
MV/+^[DHMRS7;ID.YFI X)*NU2"L9%0AP'<"[!9K;DE@IPPW^*E:4NR"0E4R-
M0H=>_<]HO!OE+.N!N>[I>#4M7^_VA#]N35U+BEL+;GLW-"9#:@ )$#I,=X7/
MF/R3X@XGL?'JA7CD(M6,D8;S7BR1K^)\?V%M)Y!LJSU U'CZ]=Z\HX2.:DN8
M^SI/7YG'C/X4 53 Q@V'A>ZZUVREIJ)RM<;]IQ)(;&Y2I:2D"-"2)F/*XLXX
MY2S!B_7C'[$Y46FOMM<IZJJ /Q4I44U#I:F#)8]K:VH>)&DS#0?D8S?BO$V4
M;U1\I.[]7!7ROA+*M.M%4NEGJ$ RL4WC]6N)*VU.KO&IYZ(:OL<JK^-]WLB]
MFYBB;J$?OE!R5FECM-3B6$42G;@];_<]T';M1/77H7!*83U,7Q\2^-LOSK(+
ME=,4:HGU"F0Q44[C":D*IR"%^V5?8M2 H>D3!EK$--?^:_DQB;EBE:74]$YJ
MPQ3V]DQRQK 7.?C*[-UZ=FHI=K<ES&+((N[/7HIEXVQA2(42G4W'<>MA\,99
M?L;L])49I67"MJZBA00T^"G8HJ2"E![2,^NLM(V Y-\!;1E'&]0]B-*BBN;U
M7^2MXA.YHM,KG2!&NQ)7)1 ,IB.I_GRC4\[_ !^9DC(#\!;([-F-H6"QR\4!
MK(L96>RA)0<72'<,J<PE=R@2,VDLW,B'E*9,1*'V#M->IMMJN;;*GF&54;K4
MYJ2%J25#122=01/0]8TN42:W$\H33U0=:N=!5R=5N+9]UI<T^D?> 4Z^/ZQS
M&<8?CMR+Q.Y3\;LZ9FQ]>;=@VFM4KE8;;8X:*P@SC,R0E6F['&U5[#Y(L2$K
M+P\#(P9W R2+<$GYT")HE,8Q"FPW8>(W;5?Z6O<]O\1AUQ>BM=9E&DO&4_"-
MIO-']P>W<K<#7K#J=AVVY]<$4])N:;)0]0,(2E04X#Z5N@*&P@]=3$K7*;YL
MLE8$J4Q;9GC9"X69),HK]+ML]VZ=7NMI?VR#F9*BR$10*Q"Q8+5>==PBS=9X
M$L*[,0\JS<$=SAF._7@V2V>ZDH]V7<_\=8UN\8<<U7*&<6S&&WUTUL=2/=6@
M&;?3[I: @>/A'(O\A7R"Y5Y[62*GKBRPG7KK'LG#%E+XOJ!*G+/6+IVRC&\!
M8;4]>3TY;7#11=+VB)E/(D0ISE$";@."'ZM_,ZE=VNU(RAAEGW29B>P> E,F
M0Z?XQM9L]LM_Q;LIX[X\RR[5SMY<6T\5N!+5.MH?S"%:A*WP9* $])G6)</A
M+XK\7^1S?CBI%8.1O&5*-E=3*'(/,#G(3B2;XY5PH4LG0ZR-#8$@UZ\IEBP2
M$>8@R02J+Y-F[,14%4!(2]\6LMOJVF*QB7\MR>OW  Z:?Y1"CY#\J\I4-TK;
M'35*+=95M--MM4BB&ZII:1[BG'.BG3KN$ONG'>0@)Q12%3;R"F43[")@[A .
M[81ZB&_[=98<V[SM^V>D0VVI3Z4;M@Z;ON_7S\8JZX0@TA!I"$QS%7YRT8HR
M;6:T*2=BLU ND! K+K*MT$9J:K4K&Q*RR[91)R@FF]=)]QTSE.4.I1 =AUP=
M;2MI2>Y!CFRZ&7VG'D>ZVET$@2'IGTU\M(X'^;?QJ8HXA\.\$9AQQ<LDV*U2
MM^<XESA"Y*1BHE.IY)AJ^HK/0,%6F\<RE4P9V2+= GWKNTQ:]B@K*=Y3FC5S
M)BE+;:)N][7%..JFN1F 3Y"-XG]M7Y'7K*LQ5P75-TC.,TK+M30**?YH"Q);
M&\]I$JUEJ2-1$0<?/?C;#$O8U\JRL$.]1D8]9NX*C)(/XQ<CI-RS;[ !%T#I
ME5W$=BC_ ##J/]7;&ZRF-+5-E-J=:(5H5 %0(UVS)!\O](VKU+]J?H*S"E5%
M.]<*A#J4,K("@-=/5()D.DY:2(TCI]Q=;3NX?'>7X@K\,6\B&<8A,3)XI=*/
MA<QMF:40J],[!(C)$+HO&J1SD_<*7Y1LB(?<N(CKGY#XQR^XX_<V[S;*MZZ6
M9QQV@J?_ -MV@4X"4%?VA3!)(22%[#*7I$:6\A1:L Y+K<9]YA-94U2DJ;"T
MS"B29:'PZ'OVAU3!(J8*H;F%-L;PMSGWW,42E5 H[_1/R[;CZ[:AW=6%J;IW
M?2Y[Z-P*5)F$@E)2H3FE6X*T5(D2(T()O5E04VNDV2:;7MGVZ Z>/Z0BV<L,
MX\Y!U E'O<>Y<,_?%D6,JS*=E+0CM$13.^BY [98$CK)"8BA1*8BQ!V$!Z"&
M2>,\]O7%=Z<O=NFJW%DH+2E>E8(F"4@]ER$^T_"+KPS.;]@%_;O6.+4JHV%H
MM]$K2K4A4R!I+Q$(!Q"X]4_CY<\_15+E9.=CU)^DUX9"PN6*,FFYB*L6<?LF
MQD&[=!5LU-9DB[F #^0# .LK_('/;OR)B.,UMZID,5BJ9Y]: %.! <6&T*&R
M<@I+6A/ZZQYV<<L7OD_+*F_W<;54K3=,4@$@%!49)E/^+J)B'T3."K!F^KB9
M;',O:ZA$S*"QWK"*+-'8S\45-XV7;"Q.X<QKI!%7N(L!2BH4P@&X"(:\SC'B
MOF*W8XO/,#M3EQI:I/L$LS5)"B%J"P% @23T,IF488R+D;$+-7FPW2MJ*"Y.
M-[CL6I&]LF4BK[2"9';.>G2-XPI5[!4YNC8Q9.;50H"R6=I#2D0V<SE;9+-[
M%+J!+I+)F!!)160(]42'O()A%381W'?68.%G.:Z7FNS8[555\M^.FN9+B'@Y
M^.4"0=3[<CZE#1)EUF8L'-QQK18'7WVV(MU7>O9/M.;FW7_<)FE4IDC:=9G0
M1G\[_!]P0S/R C:93Z=-X(+7\/R-VFY+%4H<GY60L]W1@($DE&V;\XQ!NBV@
M7YB@@1 YS[B)A -;O;WQ=B%P;53MLFE"5EUS9,EP2F3U/<3E*?@(Q1Q]\\?D
M-@56T'*Y%VM[%.EIIJK2D^VD:%*'$%*D@"7[VHTUZ1%OR>^+)3XZ,LXBRG@&
M:O'))>'4EIZ?H5B1KM=EV,<LBO!1+J#<QY5ORCH[MTJ<Y!1 2%1 WIOM"+Y.
MTV$8<IC :F[_ --J[W0+4TM25CVVTD3<4L2")$2]923TC87Q#\O+U\GL9NN)
M<CT=OME"6 A+R5..B9(6KTR($P)3)EKXR$1[?(OR+?2D]4<-/X64IXM&$1>K
M'''>*NHQ_+6&,(LQ9)@$:BF[5KBXKIF<@;M%?O* !VZP7\;^,&+12U64L.)N
M2W'%I#R2%%2$F<R9F6X=9QF_@#&<=H:6XWEBY;*INK33TA2TX9MJ.U1&U)VB
M78R,-KXES%@4Y+XI8P$C)P062W0\;,$BI!=JE(PQ5_?OHN1,V4W>-5RM-U2F
M^TVWITUD#F'^E7#CFY.U=(E+3+#WJ4 9+"#MVS[A1$CVB0?*UIM[7#-U<NI5
M5EA231J6"C<LF2B N1$M3K*>LIQT*9\5,OB&Z-E 101FPK%8 &4BHV<)A+W&
M#A]FZY2$5;'$CL>PQ3%,00W =PUK,XC;HZ;/J:H0OW$TU$]4JW),O<:84XJ8
M[R [:'L8U7Y.^Y_1Y!.NGAUA;\%PE4QQDIM9IC(?(*"CTTYR-!>EY67?3!%G
M+4J#78+$F_3]J4I=C^H[[>NI.?&WY 8W@G*%%>LPM]"+>Y3EI#U'2;'2X]Z6
MTG^=*2E$3)2-=20(P_S%QY=\FP!^FM54IU\5B'"DG9) ZF:I:CP[Q.4TP)9E
M63)U%\I.4#(CILU=$*\L.+9K9-RS*N0B@3&+7AC"!3AO]PCN'J/76^>CJVJF
M@9KO]IIUM*@E92"G< =IU(F)R,B1,:$C6-==2S^/4KIE$%2%J3/QVDB?^$8E
MWC:X13T8U3FKF5*7"/6DPA7\1Q[>2BK-N@NY670CEL4(N5@(5$Y@$H#OL(^F
MO-N&36.U52K?4U5.+J&"\&=Z2X6A,[THG,C0]/TCZ:6AK7V#6,-+72ASVRH
ME(7.4IB(R.1O+7C_ !M<K-#S1S*Y#MJKE^S,:@E+N,580A6-;=L7:,BG<Y*Q
MI8_0<5<E0>-$7R3U+9PBNB4Z)1,&L,X?\G^*\ZN3UHL=2:BJ8>+:R67FT!0.
MTR6M"4J .A()&AUC/N.?%;FG*:"LO-DM;C[%+1_DN(0XVI:6Y:!+8)4I:AJ&
MTS6?X8;&M_Y#,#39&N8UB:U$\C+)_<B;H\YDJ,E'6.X=I6V-[)4ZK+2T(>*F
MVLO8YRLG3F%W$6Y&),58I2"41$I+QNW*=JM-P11VZG54..J2DA/03\#(@_\
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ML.MAF,7?%LYM5/EMJIZ>HM3H#C3OMR<)$B%#0$1'*ZVZ[6&J>M5<D-5[:2%
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M^+L?)94C2+KO'[%&-H9HU1;L"6[,0OQC6;<02;H-:ICO'T@Q2312-L1!.1*
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MU\:^5N$:5.7F[9 >(1S:/F3,SS^,<8S:+I>(@GTLU;+*0CEHL4%19F*8X$
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MJ"7;<!*$SK=5HNEK8K4.%96V)CP\3Y$F--W(.*C&<WO&+,;"FW53E.E 2L;
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M@H9=-;M'8#=FY0W,/V_?]=MO37DMM%PD]@(R>Y7-*:9IK<Z$+62#W\(4O$%
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MZYVW&UQQ]5;@G882Q0GLHZ S*G-SP4Z4@'!7$-)U*RQB24@Q;HI 1)1L[;/
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M!54R3-O:$E"*2./9U7<H"UDMD3G'9!PL&HJY?Q1D...^[;TFJMQ4=I3J4_\
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M743*+MLNFN'135-HG.6L4VIG.0F(7>3R/CN"%4)W(E"A2%[A[I6ZU>-,)"F
MW;VNI(ABFV+ON([;ZK'*&'Y$SM6<Q<G.+..Z+^I+/1*1GN2<7BZP[)NOC&7M
M49A"TW&A,XB[H/7L5/GB'<@191J1,JBKD2&05-[98ND(E5*(#OM^WK_LV_\
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M&Z:H;&[MMMM@,(?4!^N_U#_'03!F(HH%2=LR/I D@1'?LWV'KVCMV@/J(@
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M-N3$OM,ER(EC)Z.L<2]2:2)UF$ZDJW4>^(&[A0O>0VRA=T(I\<U0_.<EFJ(
M9DTY(VWVK@FPHKK.Z7CU_+$2$!$.YI-.G"2@?14I@'J Z0AS>D(-(0:0@TA'
MCNV 1$.G_P"/V@&N*-ZON$H&0U) 3'H!W !_: #KD>L-#J.D?=(0:0@TA!I"
M#2$&D(-(0:0@TA!I"#2$&D(-(12WW#[RATZ]-Q_Q] U2?:1G'%(=/W #]8:A
M9\*9'I=FLV0>/E[91CZUR[JSVK$62T74OBNV61Y[,KZ5B)6.*:TXRGI1)J/N
M'3('[%58WD48&.)C&K'*&MR]%Y(W7F]Q9RS.87;T4,2P66JOD>VUW(,=<\<3
M>,L@5TJC"-C'[^(JEL&W,+Y'M14CU8KPF0 KDBX@3M!")5B?REW]=OV[_P">
MD(]:0@TA!I"#2$&D(-(0:0@TA!I"/@AN A^T!#I^_P#V:0AH/(;"^2[S?,/9
M(P=DVL8HR)CV7?Q5KE[-1SWME>L1SZ;=Q8L=2,8C+0RQ$W,Y&LG[=P#A-1LX
M;]R9R]Q^Y",WQ,Q1DC$] LS;+ES97?(=ZRCD+)]B?P[0L?7(I2Y39EH^OUM@
M41]I&1T0S;F.7<PF=K+&$Q]^X4(=)I"#2$&D(-(1SU_)/\U%FX#<C&N"HG L
M5DINXQ_7;L$^]NSRO+%//.Y9L:.&.2@Y$H@V_%[^05-S ;TZ:Q)GG*]%A-Q3
M;7:==0M2 2M*PD#_ /29_MC8K\1_@#5_*KCQW-+3?$VM#=<Y3EERD4\3L2%;
MMX=0-9]):>,/YPE\C&*KQB'"-_R*RE:#9,P8P@\D?@6$-8[1"1#><.^3;QJ5
MBCH=1-VX!9@8A2"F103" =O4-9(L=Q3>K8Q<4)*4OL(< )F9+2")_MB$/).$
MO<<9[=<%J'0^[:[A44A<"=H4:=Q395MF93*>DS"JJ\\^,[9FL]=7.5:I(NSL
M1*M2KH"AG1?<>-(I20)^KGVQ_$(B!3;=1#7IGK%C@@B:3,1=3_-S!U9G$*_,
M.;4@\<%.HFJC6)!RS(@DM$MEEW:Z0",>FDM,)C_U!4C&2(=4H"F7N%%8R*7-
M3CNK#1<Y^M'1&<O*O(1JF>KVGWJ<G'Q+.=?M7;$D,9VU%E%/TE53F("9 $0[
MNXI@!"/LIS/X_P )&I2LQ;'S!!>(CYU%%2LV4[M2*E&[5S'NP;IQ)C=C@KU$
MGJ(E54*F.QQ[00C[)\S^/D.\>1DC<73>58E**\7^FK.L^.<YBD!%HBWAUO>+
M%,;[BIB8Q"@)C !0$00C&1W.7CK+1;V4B[3-/R1BD.23:-:9;C2#'\V^3C6A
MU6BD*FHJ1%XJ4C@4O)X-_OV#;="+QOS9XYN(N-F"7A8C"9>3C2)<*UFU$)(_
MIMZS83;MN/X01]BP</B *I@*"A>XR?<4HB"$6@<Y>./A4>&MTH6-3FBU_P#*
MA4;2K'*RBOC]L@W7;Q*QG!'?E+XE"E%,P& 1, >B$5K)S=X[5.4>0TW;I%*3
MCW#ED[;-*K:'PIOVJYFIF)#H1 E7>*.R&2*F03&%0A@';M'2$96!YBX!L[Y"
M+A+BLZE74A Q+>,7@+!'O5)*SLY>0@&PI2$8V!,LJTA'!TE3B5 0* B< , B
MA&#><X< Q4<SD9V;GX 9%Q*M8^-E*I/!,.W,*5H:21)'LF3PY%$0?)]H&, G
M$VP!T'9"+F1YN<<HB4-"R=V=M9,$XU4K4M5MKDZI92*2G&_A!M!JF5%*(7(N
MMV@()%-L80$!#0Z"<(R-'Y?81R=,IUFCV"2EY]<)0A&*M9L;!)!6*BPEW17S
M]]&-F+;QLU$S?ZHFW4*7;N'8/GJ7S3TGY025:=!UBC9]QWVAH8;52.=\Y;+Q
M6*DYQY&L6\_8FD&J^1G'JZC1-VY]M[DC<S$A5E" .X$$P;B.VM9W'_\ <!JL
MXY<H>-D6,LFLK"Q[QJT*2WZE)W%(9$Y2Z;AUB4N1_&9VQ88_EJKBVXMEGW/9
MV$$Z3EOWR'_PPX@_-+ #/R)O+-,MC-U2H+*&IMM<-$U1;HN!*=^QAW;$G:*Y
M4S;J?TUOL/VF =;.UI*%E!()!(F.AEW'E$6DSVB8D9=.LO*,6OSNXU-%I!-Y
M<99D,<W;NUSNZ1=DP,U=EW0<(E+7U%5$=MA,;M#M*("/KKC%8O'O./C7&-FC
MJ4O3J.2?,491 7%4MIA+&N9>3@VCYT"$(M[)!Y(1"Y4_-V&,0"G$ *8!TA%N
M\YU\;&,6TG%KE)GA'\0ZF6DNA3[:JP60:2J\*=D50(4%"2RLDV,FDV.0JBH;
M&*':8!%",T/,SCV21G(M6ZJH/:U&34M.IJUVS G'-*[%1\U->5V2&.R.O'QL
MH@H=(BAE-S]H%$W32$8<>='&Y,ZY7-QDV(-UVS<ZC^GVUDD8[Q(J[51(SF&3
M,J@NEW"4X%]"&WVV#="+>,YX\:IIL]=Q%NFI%".:&D'YF])N/<UCP!J8CXY5
M81(3MUBO$S$[.XPD'NVV =(1F;+S3X\5$4OSUT<-06CVLH4R5;L[HB;%\P1E
M6JJYDH802,I'.DENSJ<"J% 0[AVTA%]%<OL'V"'1F*[.R\Z#F+L<PTBH^L6
MDX[9U*5A(2P>WC7\>R54<1\I86J0I[@93O$2=P%,((1AE>;W'I!Y7(Q>U2"$
MO:30H1D0I6K$=\"<\Z]G'KNRM8QR@U1%00,H8Q]DTS%./VF =(11<\Y^-S5U
M*L#W*24?PP.A?,V]/MZRI?9NE&"PIF)!BD8@R20MB&$Q2G6V !$.ND(^I\YN
M.*S)S*H6^26AF2#9R]F25.TA&-4G;F2:(&4<'AR"<!<Q"Y#"F4X%,4-Q^X!T
MA'J'YS<:+$HY1A+ZXD?9P[V>?J)U6W(I,8E@V]TY=.#NH-  V2V[2%[E#&,
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MV 1,4J8 81 .N^D(M?P42!E%"QL<518I"K*?CV8F4(F0R229S"CW&(FD<2E
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6(-(0:0@TA!I"#2$&D(-(0:0@TA'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
